sulfadoxine has been researched along with amodiaquine in 264 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 31 (11.74) | 18.7374 |
| 1990's | 24 (9.09) | 18.2507 |
| 2000's | 133 (50.38) | 29.6817 |
| 2010's | 54 (20.45) | 24.3611 |
| 2020's | 22 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Cheong, SL; Ng, CH; Tibon, NS | 1 |
| Baum, J; Bridgford, JL; Charman, SA; Churchyard, A; Crespo, B; Deni, I; Fidock, DA; Gahalawat, S; Gamo, FJ; Laleu, B; Lawong, A; Mittal, N; Mok, S; Niederstrasser, H; Okombo, J; Palmer, MJ; Phillips, MA; Posner, B; Ready, JM; Striepen, J; Winzeler, E; Wittlin, S; Yeo, T; Zhou, A | 1 |
| Cambournac, FJ | 1 |
| Bruce-Chwatt, LJ | 1 |
| Ghosh, SK; Sharma, VP; Yadav, RS | 1 |
| Brandling-Bennett, AD; Kamsteeg, H; Keuter, M; Khalumi, G; Ngwawe, W; Ronday, M; Sanders, J; Schouten, E; Veltkamp, S; Wetsteyn, JC | 1 |
| Breman, JG; Koplan, JP; McFarland, D; Sudre, P | 1 |
| Salako, LA; Sowunmi, A | 1 |
| Irare, SG; Lemnge, MM; Mhina, JI | 1 |
| Trigg, PI | 1 |
| Carme, B | 1 |
| Baird, JK; Bangs, MJ; Basri, H; Jones, TR; Ritonga, A | 1 |
| Phillips-Howard, PA; West, LJ | 1 |
| Brandicourt, O; Carme, B; Gay, F; Gentilini, M; Le Bras, J; Mbitsi, A; Moudzeo, H; Ndounga, M; Sathounkazi, C | 1 |
| Bjorkman, AB; Phillips-Howard, PA | 1 |
| Dinis, DV; Schapira, A | 1 |
| Fasunon, OD; Uwaifo, AO | 1 |
| Ndumbe, PM | 1 |
| Cai, XZ; Fu, SG; Huang, JK; Huang, OL; Ouyang, WC; Pang, XJ; Wang, XF; Wu, Z; Zhang, KY; Zhou, JX | 1 |
| Brubaker, G; Draper, CC; Hills, M; Kilimali, VA | 1 |
| Druilhe, P; Gentilini, M; Stahel, E | 1 |
| Feldmeier, H; Graninger, W; Kremsner, PG; Rocha, RM; Wiedermann, G; Zotter, GM | 1 |
| Cai, XZ; Fu, SG; Huang, JK; Huang, QL; Huang, XF; Pan, XJ; Quyang, WC; Wu, Z; Zhang, KY; Zhou, JX | 1 |
| Rolfe, M | 1 |
| Osanai, CH; Passos, AD; Reyes, S | 1 |
| Ball, J; Franklin, IM; Rhodes, EG | 1 |
| Bugilimfura, L; Deloron, P; Sexton, JD; Sezibera, C | 1 |
| Schapira, A; Schwalbach, JF | 1 |
| Biddulph, J | 1 |
| Bada, JL; Gascon, J; Merlos, A; Soldevila, M | 1 |
| Chiodini, PL | 1 |
| Charmot, G; Le Bras, J; Simon, F | 1 |
| Brandicourt, O; Brasseur, P; Brucker, G; Danis, M; Datry, A; Druilhe, P; Duflo, B; Gentilini, M; Rosenheim, M | 1 |
| Campbell, CC; Heymann, DL; Khoromana, CO; Wirima, JJ | 1 |
| Dixon, PA; Makanjuola, RO; Oforah, E | 1 |
| Fox, E; Khaliq, AA; Macdonald, M; Sarwar, M; Strickland, GT | 1 |
| Arias, AE; Cortes, GT; Espinal, CA; Guerra, P | 1 |
| Spencer, HC | 1 |
| Salako, LA | 1 |
| Boriga, DA; Kariuki, DM; Kipingor, T; Koech, DK; Sixsmith, DG; Spencer, HC; Watkins, WM | 1 |
| Rieckmann, KH | 1 |
| Phillips, RE | 1 |
| Darlow, B; Stace, J; Vrbova, H | 1 |
| Alvar, J; Amela, C; Benito, A; Molina, R; Roche, J | 1 |
| Bekobita, D; Munafu, CG; Nevill, CG; Ochen, K; Sezi, CL | 1 |
| Del Nero, L; Lamizana, L; Nebié, I; Pietra, V | 1 |
| Burnham, G; Kamugisha, J; Kipp, W | 1 |
| Yang, H; Yang, P; Yang, Y | 1 |
| Hagos, B; Kariuki, D; Khan, B; Martin, SK; Ofulla, AV | 1 |
| Alvar, J; Amela, C; Ayecaba, S; Benito, A; Molina, R; Roche, J | 1 |
| Afshar, A; Edrissian, GH; Mohsseni, G; Satvat, MT; Sayedzadeh, A | 1 |
| Drakeley, C; Greenwood, B; Jaffar, S; Joof, D; Müller, O; Okorie, C; Pinder, M; van Hensbroek, MB | 1 |
| Anabwani, GM; Esamai, FO; Menya, DA | 1 |
| Greenwood, BM; McIntosh, HM | 1 |
| Makonnen, E; Mengesha, T | 1 |
| McIntosh, HM | 2 |
| Ashruf, G; Bennebroek, J; Gikunda, S; Gorissen, E; Kager, PA; Lamboo, M; Mbaruku, G | 1 |
| Basco, LK; Keundjian, A; Ringwald, P; Same Ekobo, A | 1 |
| Blair, S; Fonseca, JC; Lacharme, LL; Tobón, A | 1 |
| Charlebois, ED; Dorsey, G; Gasasira, A; Kamya, MR; Ndeezi, G; Rosenthal, PJ; Staedke, SG | 1 |
| Robert, V; Sokhna, CS; Trape, JF | 1 |
| Basco, LK; Blackett, KN; Keundjian, A; Ngouesse, B; Ringwald, P | 1 |
| Adjetey, TA; Barro-Kiki, PC; Konan, YJ; Koné, M; Menan, EI; Nebavi, NG; Nigué, L; Yavo, W | 1 |
| Blair-Trujillo, S; Carmona-Fonseca, J; Lacharme-Lora, L | 1 |
| Sowunmi, A | 2 |
| Basco, LK; Metoh, T; Ndounga, M; Ngane, VF; Ringwald, P; Same-Ekobo, A; Soula, G | 1 |
| Basco, LK; Ringwald, P | 1 |
| Alonso, PL; Aponte, JJ; Drakeley, C; Kahigwa, E; Malende, A; Menendez, C; Mshinda, H; Msokame, C; Schellenberg, D; Tanner, M; Wigayi, J | 1 |
| Cheng, Q; Rieckmann, K | 1 |
| Aubouy, A; Bakary, M; Cot, M; Deloron, P; Keundjian, A; Le Bras, J; Makita, JR; Mbomat, B; Migot-Nabias, F | 1 |
| Dorsey, G; Gasasira, AF; Kamya, MR; Nassali, A; Nzarubara, B; Rosenthal, PJ; Staedke, SG | 1 |
| Cattamanchi, A; Dorsey, G; Hubbard, A; Kyabayinze, D; Rosenthal, PJ | 1 |
| Giraldo, LE; González, IJ; Padilla, JO; Saravia, NG | 1 |
| Ericsson, O; Gustafsson, LL; Hipolite, D; Massele, AY; Minzi, OM; Moshi, MJ; Tomson, G | 1 |
| Mussano, P; Olliaro, P | 1 |
| Makama, S; Shabahang, J; Tavrow, P | 1 |
| D'Alessandro, U; Dujardin, JC; Karema, C; Mugisha, V; Niyitegeka, F; Rwagacondo, CE; Sarushi, J; van den Ende, J; Van Overmeir, C | 1 |
| Fateye, BA; Sowunmi, A | 1 |
| Dorsey, G; Kamya, MR; Rosenthal, PJ; Staedke, SG; Vlahos, J | 1 |
| Abacassamo, F; Alonso, PL; Aponte, JJ; Barreto, A; Enosse, S; Gómez-Olivé, FX; Mabunda, S; Magnussen, P; Quintó, L; Rønn, AM; Thompson, R | 1 |
| Bakyaita, N; D'Alessandro, U; Egwang, TG; Langi, P; Mutabingwa, TK; Nalunkuma-Kazibwe, A; Talisuna, AO; Van Marck, E; Watkins, WW | 1 |
| Ardizzoni, E; Bakyaita, N; Balkan, S; Brockman, A; Checchi, F; Guthmann, JP; Klarkowski, D; Kosack, C; Kwezi, E; Piola, P; Priotto, G | 1 |
| Majori, G | 1 |
| Cassano, F; Cavailler, P; Guthmann, JP; Kariuki, D; Mwangi, J; Omar, SA; Piola, P; Stivanello, E | 1 |
| Adedeji, AA; Fateye, BA; Fehintola, FA; Happi, TC; Sowunmi, A | 1 |
| Adedeji, AA; Babalola, CP; Fateye, BA; Sowunmi, A | 1 |
| Cobelens, FG; Gikunda, S; Hoogstraatte, SR; Kager, PA; Scheper, FY; Smolders, M; Vreugdenhil, CJ | 1 |
| Dokomajilar, C; Dorsey, G; Kamya, MR; Kiggundu, M; Rosenthal, PJ; Staedke, SG | 1 |
| Baerwaldt, T; Checchi, F; Danks, A; Durand, R; Heinzelmann, A; Hora, B; Kamara, S; Lamotte, Nd; Morineau, G; Oloo, A; Pinoges, L; Ranford-Cartwright, L; Roddy, P; Smet, M; Williams, A; Wurie, AR | 1 |
| Amankwa, J; Ansah, NA; Ansah, P; Anto, F; Anyorigiya, T; Atuguba, F; Hodgson, A; Mumuni, G; Oduro, AR | 1 |
| Al-Faith, M; Alemu, E; Amsalu, R; Balasegaram, M; Checchi, F; Hepple, P; Hussein, el B; Montgomery, J; van den Broek, I | 1 |
| Göbels, K; Graupner, J; Grobusch, MP; Häussinger, D; Lund, A; Richter, J | 1 |
| Atkin, S; Checchi, F; Ford, N; Hamour, S; Hook, C; Keus, K; Melaku, Y; Montgomery, J; Wambugu, J | 1 |
| Ampuero, J; Balkan, S; D'Alessandro, U; Denoncin, A; Dujardin, JC; Dunand, J; Fortes, F; Franco, J; Gaboulaud, V; Gillet, P; Guthmann, JP; Legros, D; Saraiva, N; Tobback, S; van Herp, M; van Overmeir, C | 1 |
| Bakyaita, N; Banek, K; Dorsey, G; Kamya, MR; Kilian, A; Kironde, F; Nsobya, S; Reingold, A; Rosenthal, PJ; Staedke, SG; Talisuna, A; Wabwire-Mangen, F; Yeka, A | 1 |
| Djalle, D; Koula, MR; Madji, N; Manirakiza, A; Menard, D; Talarmin, A | 1 |
| Anemana, SD; Bienzle, U; Cramer, JP; Dzisi, SY; Eggelte, TA; Ehrhardt, S; Mockenhaupt, FP; Otchwemah, RN; Sauerwein, RW; Schreiber, J; Teun Bousema, J; Wassilew, N | 1 |
| Ahmad, F; Durrani, N; Graham, K; Leslie, T; Rahim, S; Rowland, M | 1 |
| Aguttu, C; Kaddumukasa, M; Kironde, F; Nassejje, M; Ndagire, D; Pettersson, M; Sendagire, H; Swedberg, G | 1 |
| Bakyaita, N; Banek, K; Dorsey, G; Kamya, MR; Kilian, A; Kironde, F; Nsobya, SL; Reingold, A; Rosenthal, PJ; Slater, M; Staedke, SG; Talisuna, A; Wabwire-Mangen, F; Yeka, A | 1 |
| Abuaku, B; Duah, N; Koram, KA; Quashie, N | 1 |
| Garner, P; Jones, K; Taylor-Robinson, D | 1 |
| Abdulla, KH; Abdulla, R; Ali, AS; Fakih, K; Juma, MS; Lemnge, MM; Malecela, EK; Njau, RJ; Sambu, E | 1 |
| Jones, KL; McIntosh, HM | 1 |
| Adedeji, AA; Fateye, BA; Fehintola, FA; Gbotosho, GO; Happi, TC; Oduola, AM; Sowunmi, A; Tambo, E | 1 |
| Adjetey, TA; Affoumou, GB; Barro-Kiki, P; Kone, M; Loukou, DD; Menan, EI; Nebavi, NG; Yavo, W | 1 |
| Alker, AP; Meshnick, SR | 1 |
| Dokomajilar, C; Dorsey, G; Lankoande, M; Ouedraogo, JB; Rosenthal, PJ; Rouamba, N; Zongo, I | 1 |
| Bachy, C; D'Alessandro, U; Donam, I; Grandesso, F; Guthmann, JP; Habimana, J; Kerah, CH; Maikere, J; Ntambi, J; Vanlerberghe, V | 1 |
| Amin, AA; Kokwaro, GO; Snow, RW | 1 |
| Bukirwa, H; Critchley, J | 1 |
| Dokomajilar, C; Dorsey, G; Francis, D; Kamya, MR; Machekano, R; Nsobya, SL; Rosenthal, PJ; Talisuna, A; Yeka, A | 1 |
| English, M; Midia, B; Ochola, SA; Snow, RW; Zurovac, D | 1 |
| Abdulla, S; Bloland, PB; Causer, LM; Elling, BF; Goodman, CA; Kassala, H; Khatib, RA; Mkikima, S; Patrick Kachur, S; Schulden, J | 1 |
| Abdulla, S; Bloland, P; Mandike, R; Mills, A; Mulligan, JA; Palmer, N; Williams, H | 1 |
| D'Alessandro, U; Fanello, CI; Karema, C; Rwagacondo, CE; van Doren, W | 1 |
| Boulanger, D; Capuano, F; Cisse, B; Dieme, JL; Dieng, Y; Greenwood, B; Ndiaye, T; Remoue, F; Simondon, F; Sokhna, C; Trape, JF | 1 |
| Bitarakwate, E; Dorsey, G; Hwang, J; Pai, M; Reingold, A; Rosenthal, PJ | 1 |
| Dokomajilar, C; Dorsey, G; Lankoande, ZM; Ouedraogo, JB; Rosenthal, PJ; Zongo, I | 1 |
| Lalou, R; Le Hesran, JY; Sene, I; Souares, A; Sow, D | 3 |
| Aubouy, A; Deloron, P; Migot-Nabias, F | 1 |
| Balkan, S; Checchi, F; Cousens, S; Guthmann, JP; Legros, D; Olliaro, P; Pinoges, L; van Herp, M | 1 |
| Abodo, RT; Basco, LK; Ndounga, M; Ngane, VF; Same-Ekobo, A; Soula, G; Youmba, JC | 1 |
| Juma, EA; Lau, J; Obonyo, CO; Ogutu, BR; Vulule, JM | 1 |
| Kayembe, G; Montgomery, J; Pota, H; Roper, C; Swarthout, TD; van den Broek, IV | 1 |
| D'Alessandro, U; Fanello, CI; Karema, C; Ngamije, D; van Doren, W; Van Overmeir, C | 1 |
| Kim, M; Mutabingwa, TK; Whitty, CJ; Wiseman, V | 1 |
| D'Alessandro, U; ter Kuile, FO | 1 |
| Browne, E; Bruce, J; Chandramohan, D; Greenwood, B; Randal, A; Tagbor, H | 1 |
| Bell, DJ; Molyneux, ME; Nyirongo, SK; Ward, SA; Winstanley, PA | 1 |
| Aguttu, C; Anokbonggo, WW; Chiria, J; Gustafsson, LL; Hellgren, U; Obua, C; Ogwal-Okeng, JW | 1 |
| Adam, I; Alifrangis, M; Elmardi, KA; Ibrahium, AM; Khalil, IF; Kheir, MM; Malik, EM; Osman, ME | 1 |
| Morrow, RH | 1 |
| Dokomajilar, C; Dorsey, G; Guiguemde, RT; Ouedraogo, JB; Rosenthal, PJ; Rouamba, N; Tinto, H; Zongo, I | 1 |
| Adedeji, AA; Fateye, BA; Gbotosho, GO; Happi, TC; Sowunmi, A | 1 |
| Bonnet, M; Coulibaly, L; Félix, M; Guthmann, JP; Kankolongo, GM; Roper, C | 1 |
| Andrianina, NN; Jahevitra, M; Ménard, D; Ramiandrasoa, Z; Randriamanantena, A; Rasoarilalao, N; Ratsimbasoa, A; Raveloson, A; Tuseo, L | 1 |
| Clark, TD; Dokomajilar, C; Dorsey, G; Kamya, MR; Maiteki-Sebuguzi, C; Njama-Meya, D; Nzarubara, B; Rosenthal, PJ; Staedke, S | 1 |
| González, IJ; Osorio, L; Pérez, Ldel P | 1 |
| Ariey, F; Bedja, SA; Rabarijaona, LP; Randrianarivelojosia, M; Robert, V; Tall, A | 1 |
| Dieng, Y; Faye, B; Faye, O; Gaye, O; Ndiaye, D; Ndiaye, JL | 1 |
| Basco, LK; Casimiro, PN; Mallanda, G; Malonga, DA; Matondo Maya, DW; Mayengue, PI; Miakassissa-Mpassi, V; Ndounga, M; Nsonde-Ntandou, F; Ntoumi, F; Ringwald, P; Tahar, R | 1 |
| Nyunt, MM; Plowe, CV | 1 |
| Beck, HP; Genton, B; Goroti, M; Maku, P; Marfurt, J; Müeller, I; Reeder, JC; Sie, A | 1 |
| Dokomajilar, C; Dorsey, G; Ouédraogo, JB; Rosenthal, PJ; Rouamba, N; Séré, Y; Zongo, I | 1 |
| Alifrangis, M; Bygbjerg, IC; Enevold, A; Jensen, AT; Nkya, WM; Staalsoe, T; Theander, TG; Theisen, M; Vestergaard, LS | 1 |
| Freund, RJ; Lombrail, P; Malvy, D; Millet, P; Nzayirambaho, M; Potel, G | 1 |
| Eriksen, J; Gustafsson, LL; Kitua, A; Mduma, S; Mwankusye, S; Petzold, MG; Swedberg, G; Tomson, G; Veiga, MI; Warsame, M | 1 |
| Bâ, el H; Boulanger, D; Cissé, B; Gaye, O; Greenwood, B; Hallett, R; Lines, J; Milligan, P; Simondon, F; Simondon, K; Sokhna, C; Sutherland, C; Targett, G; Trape, JF | 1 |
| Akida, JA; Lemnge, MM; Lugimbana, L; Malebo, HM; Malle, LN; Segeja, MD | 1 |
| Bouyou-Akotet, M; Durand, R; Guiyedi, V; Kombila, M; Le Bras, J; Loembet, R; Mabika-Mamfoumbi, M; Mourou-Mbina, JR; Ngoungou, E; Nsimba, B | 1 |
| Arens, T; Bousema, JT; Drakeley, CJ; Gouagna, LC; Houben, R; Mens, PF; Omar, SA; Sauerwein, RW; Schallig, H | 1 |
| Dama, S; Dembele, D; Dicko, A; Djimdé, AA; Doumbo, OK; Fofana, B; Ouologuem, D; Sagara, I; Sidibe, B; Toure, S | 1 |
| Kolawole, SO; Ogungbamigbe, TO; Ogunro, PS; Ojurongbe, O; Okanlawon, BM | 1 |
| Beck, HP; Genton, B; Marfurt, J; Müller, I; Oa, O; Reeder, JC; Sie, A; Smith, TA | 1 |
| Ahouidi, AD; Daily, JP; Ly, O; Mboup, S; Ndiaye, D; Ndir, O; Sarr, O; Wirth, DF | 1 |
| Clark, TD; Dorsey, G; Jagannathan, P; Kamya, MR; Maiteki-Sebuguzi, C; Njama-Meya, D; Nzarubara, B; Rosenthal, PJ; Staedke, SG; Talisuna, AO; Yau, VM | 1 |
| Barbollat, L; Beck, HP; Brega, S; de Monbrison, F; Genton, B; Goroti, M; Marfurt, J; Müller, I; Picot, S; Reeder, JC; Sie, A | 1 |
| Brooker, S; Clarke, SE; Crudder, C; Cundill, B; Estambale, BB; Jukes, MC; Khasakhala, L; Njagi, JK; Otido, J | 1 |
| Cortés, LJ; Guerra, AP; Knudson, A; Nicholls, RS; Pérez, MA; Usta, C | 1 |
| Ashley, EA; Balkan, S; Bukirwa, H; Checchi, F; Dorsey, G; Guthmann, JP; Olliaro, P; Pinoges, L; Taylor, WR; Turyakira, E; Urruta, PP; van den Broek, I; van Herp, M; Zongo, I | 1 |
| Arango, E; Blair, S; Carmona-Fonseca, J | 1 |
| Affipunguh, PK; Bruce, J; Chandramohan, D; Clerk, CA; Greenwood, B; Hodgson, A; Mensah, N | 1 |
| Briand, V; Buffet, PA; Danis, M; Mazier, D; Rénia, L; Thellier, M | 1 |
| Atta, H; Elmi, HH; Hassan, AM; Hassan, HM; Jibril, AM; Klena, JD; Waqar, BA; Warsame, M | 1 |
| Alker, AP; Bloland, PB; Kazadi, WM; Kutelemeni, AK; Meshnick, SR; Tshefu, AK | 1 |
| Adjuik, M; Binka, F; Chandramohan, D; Greenwood, B; Kweku, M; Liu, D; Seidu, M | 1 |
| Avellino, P; Bancone, G; d'Alessandro, U; Fanello, CI; Karema, C; Lee, SJ; Modiano, D; Uwimana, A | 1 |
| Billal, DS; Hotomi, M; Yamanaka, N | 1 |
| Djimde, A; Doumbo, OK; Guirou, EA; Hoppe, A; Kayentao, K; Kone, Y; Maiga, H; McMorrow, ML; Newman, RD; Saye, R; Traore, B; Traore, H; Yattara, O | 1 |
| Clark, TD; Dorsey, G; Greenhouse, B; Hubbard, A; Kamya, MR; Maiteki-Sebuguzi, C; Njama-Meya, D; Nzarubara, B; Rosenthal, PJ; Slater, M; Staedke, SG | 1 |
| Beavogui, AH; Dama, S; Dembele, D; Dicko, A; Djimde, AA; Doumbo, OK; Fofana, B; Kone, A; Maiga, H; Ouologuem, D; Sagara, I; Tekete, M; Wele, M | 1 |
| Briceño, M; Drakeley, C; Greenwood, BM; Mutabingwa, TK; Muze, K; Ord, R; Whitty, CJ | 1 |
| Adeothy, A; Amedome, H; Aubouy, A; Cot, M; Cottrell, G; Deloron, P; Doritchamou, J; Faucher, JF; Gourmel, B; Houzé, P; Kossou, H; Massougbodji, A | 1 |
| Bley, D; Gausseres, M; Malvy, D; Millet, P; Sayang, C; Vernazza-Licht, N | 1 |
| Ashley, E; Bonnet, M; Broek, Iv; Guthmann, JP; Kyomuhendo, J; Ndosimao, CN; Urrutia, PP; van Herp, M; van Overmeir, C | 1 |
| Boly, MD; Deloron, P; Faucher, JF; Houzé, S; Le Bras, J | 1 |
| Cairns, M; Chandramohan, D; Gesase, S; Gosling, R; Greenwood, B; Mosha, J | 1 |
| Abudey, S; Adjuik, M; Chandramohan, D; Greenwood, B; Kweku, M; Webster, J | 1 |
| Aprioku, JS; Obianime, AW | 2 |
| Joloba, M; Kiggundu, M; Nawaz, F; Nsobya, SL; Rosenthal, PJ | 1 |
| Carlotti, MP; Lalou, R; Le Hesran, JY; Moulin, P; Sarrassat, S; Souares, A | 1 |
| Baisor, M; Beck, HP; Genton, B; Hastings, IM; Marfurt, J; Müller, I; Oa, O; Reeder, JC; Sie, A; Smith, TA | 1 |
| Ba, EH; Cairns, M; Cames, C; Cisse, B; Gaye, O; Greenwood, BM; Milligan, PJ; Simondon, K; Sokhna, C; Trape, JF | 1 |
| Ajua, A; Ateh, IA; Echouffo-Tcheugui, JB; Evehe, MS; Greenwood, B; Hallett, R; Irenee, D; Mbacham, WF; Mimche, PN; Netongo, PM; Nji, AM; Roper, C; Targett, G; Tawe, B | 1 |
| Basco, LK; Foumane, VN; Gwét, H; Soula, G; Tahar, R; Thalabard, JC; Whegang, SY | 1 |
| Dokomajilar, C; Greenhouse, B; Ouédraogo, JB; Rosenthal, PJ; Rouamba, N; Séré, YY; Somé, AF; Zongo, I | 1 |
| Bousema, T; Drakeley, C; Ghani, AC; Griffin, JT; Okell, L; Omar, S; Sauerwein, R; Sawa, P; Shekalaghe, S; Sutherland, C | 1 |
| Basco, LK; Gwét, H; Thalabard, JC; Whegang, SY | 1 |
| Clark, TD; Dorsey, G; Greenhouse, B; Kamya, MR; Maiteki-Sebuguzi, C; Njama-Meya, D; Nzarubara, B; Rosenthal, PJ; Staedke, SG | 1 |
| Chandramohan, D; Conteh, L; Greenwood, B; Kweku, M; Legood, R; Patouillard, E | 1 |
| Chandramohan, D; Färnert, A; Greenwood, B; Kweku, M; Liljander, A; Montgomery, SM; Olsson, D | 1 |
| Bojang, KA; Greenwood, BM; Milligan, P; Sesay, S; Sowe, M; Touray, E; Webb, EL | 1 |
| Beeson, JG; Fowkes, FJ; Mueller, I; Richards, JS; Rogerson, SJ | 1 |
| Akor, F; Bittaye, O; Bojang, KA; Conteh, L; Conway, DJ; Greenwood, B; Jasseh, M; Milligan, PJ; Webb, E; Wiseman, V | 1 |
| Chandramohan, D; Cousens, S; Diallo, DA; Diarra, A; Gansané, A; Greenwood, B; Kaboré, Y; Kangoyé, DT; Konaté, AT; Milligan, PJ; Ouédraogo, A; Ouédraogo, AZ; Ouédraogo, E; Ouédraogo, IN; Sirima, SB; Soulama, I; Tiono, AB; Yaro, JB | 1 |
| Mishra, SK; Rath, SK; Singh, P | 1 |
| Barry, A; Chandramohan, D; Conaré, T; Cousens, S; Dara, N; Diallo, AI; Diallo, DA; Dicko, A; Dicko, M; Dicko, Y; Doumbo, OK; Greenwood, B; Milligan, PJ; Santara, G; Sidibe, Y; Tembine, I | 1 |
| Chandramohan, D; Cousens, S; Diallo, DA; Diarra, A; Gansané, A; Greenwood, BM; Kaboré, Y; Kangoyé, DT; Konaté, AT; Milligan, PJ; Ouédraogo, A; Ouédraogo, AZ; Ouédraogo, E; Ouédraogo, IN; Sirima, SB; Soulama, I; Tiono, AB; Yaro, JB | 1 |
| Baliraine, FN; Rosenthal, PJ | 1 |
| Barnes, KI; Beavogui, AH; Djimde, AA; Doumbo, OK; Evans, A; Fredericks, A; Maiga, H; Sangare, CP; Smith, P; Tekete, MM; Toure, S; Traore, ZI | 1 |
| Cissé, M; Lalou, R; Le Hesran, JY; Sarrassat, S | 1 |
| Bassene, C; Bygbjerg, IC; Faye, B; Gaye, O; Magnussen, P; Ndiaye, JL; Ndiaye, M; Ndour, CT; Ndour, JD; Sylla, K; Tine, RC | 1 |
| Arango, EM; Carmona-Fonseca, J; Upegui, YA | 1 |
| Aponte, JJ; Barnadas, C; Beeson, JG; Iga, J; Ley, S; Manong, D; Mueller, I; Rarau, P; Reeder, JC; Robinson, L; Rogerson, SJ; Rosanas-Urgell, A; Salib, M; Schofield, L; Senn, N; Siba, P; Stanisic, DI; Tarongka, N; Zimmerman, PA | 1 |
| Dembele, D; Dicko, A; Djimde, AA; Doumbo, OK; Fofana, B; Gaudart, J; Giorgi, R; Sagara, I; Sanogo, K; Sidibe, B; Togo, A; Toure, S | 1 |
| Baird, JK; de Monbrison, F; Laihad, F; Picot, S; Ruckert, P; Suprianto, S; Sutanto, I; von Bethmann, A; Widiaty, A | 1 |
| Angheben, A; Bisoffi, Z; Buonfrate, D; Gobbi, F; Sirima, BS; Tinto, H; Van den Ende, J | 1 |
| Benito, A; Berzosa, P; Charle, P; de Lucio, A; Nseng Nchama, G; Raso, J | 1 |
| Abiola, A; Ba, el-H; Cairns, M; Cisse, B; Dieng, Y; Faye, B; Faye, O; Gaye, O; Gomis, JF; Hallett, R; Lo, AC; Milligan, P; Ndiaye, D; Ndiaye, JL; Ndiaye, M; Ndir, O; Sokhna, C; Sutherland, C; Tine, R | 1 |
| Dondorp, AM; Faiz, MA; Hien, TT; Mokuolu, OA; Pukrittayakamee, S; White, NJ | 1 |
| Aubouy, A; Dahlström, S; Deloron, P; Ezinmègnon, S; Faucher, JF; Houzé, P; Houzé, S; Kendjo, E; Le Bras, J; Maïga-Ascofaré, O; Massougbodji, A; Wakpo, A | 1 |
| Bouyou-Akotet, MK; Kombila, M; Mawili-Mboumba, DP | 1 |
| Akindeh-Nji, M; Ali, IM; Atogho-Tiedeu, B; Baldip, K; Diakite, M; Domkam, IK; Evehe, MS; Lamb, T; Mbacham, WF; Mimche, PN; Netongo, PM; Ngora, H; Ranford-Cartwright, L | 1 |
| Beavogui, AH; Dama, S; Dara, A; Dembele, D; Diallo, N; Djimde, AA; Doumbo, OK; Maiga, H; N'Dong, C; Niangaly, H; Sagara, I; Sangare, CP; Tekete, M; Toure, O; Traore, OB; Traore, ZI | 1 |
| Compaore, YD; Greenwood, B; Milligan, P; Nosten, F; Ouedraogo, JB; Rosenthal, PJ; Some, AF; Sutherland, C; Tarning, J; Zongo, I | 1 |
| Adiossan, LG; Brittenham, GM; Diakité, VG; Glinz, D; Hurrell, RF; N'Goran, EK; Ouattara, M; Righetti, AA; Seifert, B; Utzinger, J; Wegmüller, R; Zimmermann, MB | 1 |
| Acheampong, PR; Antwi, GD; Bart Plange, C; Cairns, M; Chandramohan, D; Tagbor, H | 1 |
| Grobusch, MP; Hakizimana, E; Kateera, F; Kumar, N; Mens, PF; Mutesa, L; Nsobya, SL; Tukwasibwe, S; van Vugt, M | 1 |
| Ba, EH; Cairns, M; Cissé, B; Fall, FB; Faye, B; Gaye, O; Gomis, JF; Greenwood, BM; Kouevijdin, E; Milligan, PJ; Molez, JF; NDiaye, JL; Ndour, CT; Niane, FK; Rogier, C; Sokhna, C; Trape, JF | 1 |
| Arez, AP; Berzosa, P; de Sousa, B; Guerra, M; Mendes, C; Ndong-Mabale, N; Neres, R; Salgueiro, P | 1 |
| Ba, EH; Cairns, M; Cissé, B; Dial, Y; Fall, FB; Faye, B; Faye, E; Faye, O; Faye, OK; Faye, S; Flach, C; Gaye, O; Gomis, JF; Greenwood, B; Konate, L; Kouevijdin, E; Lo, A; Milligan, P; NDiaye, JL; NDiaye, M; Pitt, C; Sokhna, C; Sutherland, C; Sy, O; Thior, PM; Tine, R; Trape, JF | 1 |
| Liu, XJ; Peng, HJ; Wei, HX; Xia, J; Zhou, LJ | 1 |
| York, A | 1 |
| Clark, RL | 1 |
| Aprioku, JS; Mankwe, AC | 1 |
| Diallo, M; Diawara, F; Diawara, H; Dicko, A; Djimde, AA; Eckert, E; Kamate, B; Kone, D; Kone, DT; Mahamar, A; Mihigo, J; Sadou, A; Sagara, I; Steinhardt, LC; Traore, T | 1 |
| Cissé, B; Conteh, L; Gaye, O; Gomis, JF; Hadj Ba, E; Milligan, PJ; Ndiaye, JL; Ndiaye, M; Pitt, C; Sy, O | 1 |
| Coldiron, ME; Grais, RF; Von Seidlein, L | 1 |
| Bousema, T; Bradley, J; Brown, JM; Chen, I; Diarra, K; Diawara, H; Dicko, A; Drakeley, C; Gosling, R; Hwang, J; Issiaka, D; Keita, S; Kone, DT; Lanke, K; Mahamar, A; McCulloch, C; Müller, O; Roh, ME; Sanogo, K; Soumare, HM; Srinivasan, V; Stone, WJR; Traore, SF | 1 |
| Allen, EN; Barnes, KI; Bell, DJ; de Kock, M; Denti, P; Djimde, AA; Tarning, J; Tekete, MM; Ward, SA; Workman, L | 1 |
| Amambua-Ngwa, A; Bouriema, SH; D'Alessandro, U; Fandeur, T; Grais, RF; Guérin, PJ; Laminou, IM; Langendorf, C; Makarimi, R; Sibley, CH; Woi-Messe, L | 1 |
| Barry, A; Cairns, M; Chandramohan, D; Coumare, S; Diarra, M; Dicko, A; Doumbo, O; Greenwood, B; Kuepfer, I; Milligan, P; Nikiema, F; Ouedraogo, JB; Sagara, I; Tapily, A; Thera, I; Tinto, H; Traore, A; Yerbanga, S; Zongo, I | 1 |
| Djimde, AA; Djimde, M; Doumbo, OK; Fofana, B; Jacobs, J; Mgina, EJ; Niangaly, H; Sagara, I; Samouda, H; Sombie, SB; Tekete, M; Vaillant, M | 1 |
| Abdel-Muhsin, AA; Abdelraheem, MH; Al Dhuhli, A; Al Hosni, A; Al Rubkhi, M; Al-Hamidhi, S; Babiker, HA; Bakhiet, AMA; Gadalla, A; Gismelseed, L; Kheir, A; Mukhtar, M; Naiem, A; Omer, S; Sultan, AA | 1 |
| Attaher, O; Barry, A; Cisse, KB; Coulibaly, B; Dembele, A; Diarra, BS; Diarra, K; Dicko, A; Duffy, PE; Fried, M; Issiaka, D; Kanoute, MB; Keita, S; Kwan, JL; Mahamar, A; Samassekou, MB; Sissoko, S; Traore, T; Zaidi, I | 1 |
| Chandramohan, D; Compaore, YD; Frédéric, N; Greenwood, B; Hema-Ouangraoua, S; Kabore, NF; Kuepfer, I; Ouedraogo, JB; Tinto, H; Yerbanga, RS; Zongo, I | 1 |
| Anvikar, AR; Ashley, EA; Chandramohan, D; Cohee, LM; D'Alessandro, U; Genton, B; Gilder, ME; Guérin, PJ; Juma, E; Kalilani-Phiri, L; Kennon, K; Kuepfer, I; Laufer, MK; Lwin, KM; Mansoor, R; McGready, R; Meshnick, SR; Mosha, D; Mwapasa, V; Mwebaza, N; Nambozi, M; Ndiaye, JA; Nosten, F; Nyunt, M; Ogutu, B; Parikh, S; Paw, MK; Phyo, AP; Pimanpanarak, M; Piola, P; Rijken, MJ; Saito, M; Sriprawat, K; Stepniewska, K; Tagbor, HK; Tarning, J; Tinto, H; Valéa, I; Valecha, N; White, NJ; Wiladphaingern, J | 1 |
| Abuaku, B; Ahorlu, C; Awandare, G; Ghansah, A; Koram, KA; Mensah, BA; Myers-Hansen, JL; Ngwa, AA; Oyebola, MK; Wilson, MD | 1 |
| Abdoulaye Louis Padounou, M; Adamou, R; Courtin, D; Diallo, A; Ibrahim, ML; Mahaman Moustapha, L; Ndiaye, JLA; Testa, J | 1 |
| Cairns, M; Conteh, L; Diawara, F; Diawara, H; Dicko, A; Duval, L; Eckert, E; Kamate, B; Mihigo, J; Sadou, A; Sagara, I; Sicuri, E; Steinhardt, LC; Walker, P | 1 |
| Hughes, E; Jagannathan, P; Mohamed Ali, A; Savic, RM; Wallender, E | 1 |
| Esu, EB; Meremikwu, MM; Oringanje, C | 1 |
| Belem, AMG; Chandramohan, D; Cohuet, A; Compaoré, YD; Greenwood, B; Lefèvre, T; Nikièma, F; Ouattara, SB; Ouédraogo, JB; Tinto, H; Yaméogo, KB; Yao, FA; Yerbanga, RS; Zongo, I | 1 |
| Bojang, K; Cairns, M; Ceesay, SJ; Diallo, A; Dicko, A; Eloike, T; Gamougam, K; Kessely, H; Merle, C; Milligan, P; Moroso, D; Ndiaye, JL; Ogboi, JS; Ouedraogo, JB; Sagara, I; Scott, S; Snell, P; Van Hulle, S; Zongo, I | 1 |
| Counihan, H; de Cola, MA; Diar, MSI; Moukenet, A; Rassi, C; Richardson, S; Roca-Feltrer, A | 1 |
| Agboraw, E; Churcher, TS; Diarra, A; Lambert, B; Lankouande, M; Lindsay, SW; Ouedraogo, A; Ouedraogo, ZA; Ranson, H; Sagnon, N; Sanou, A; Soulama, I; Tiono, AB; Traore, A; Wilson, AL; Worrall, E; Yaro, JB | 1 |
| Attaher, O; Barry, A; Dembele, AB; Diarra, BN; Dicko, A; Djimde, A; Duffy, PE; Freedman, B; Fried, M; Issiaka, D; Kanoute, MB; Levitt, B; Mahamar, A; Sagara, I; Sumner, KM; Taylor, SM; Traore, A | 1 |
| Chotsiri, P; Tarning, J; White, NJ | 1 |
| Bamadio, A; Chico, RM; Cohee, LM; Coumare, S; Dara, A; Diarra, M; Djimde, AA; Doumbo, OK; Kodio, A; Maiga, H; Opondo, C; Sagara, I; Sidibe, B; Tekete, M; Traore, OB; Traore, ZI | 1 |
| Clapp, S; Freedman, B; Green, CL; Kirui, JK; Korwa, S; Njuguna, FM; O'Meara, WP; Taylor, SM; Wu, A | 1 |
| Bazie, T; Beshir, KB; Bojang, K; Cairns, M; Ceesay, S; Diallo, A; Dicko, A; Doumagoum, D; Eloike, T; Gamougam, K; Kessely, H; Kolie, F; Lamine, MM; Laminou, IM; Loua, K; Maiga, H; Mansukhani, R; Merle, CS; Milligan, P; Moroso, D; Muwanguzi, J; Nader, J; NDiaye, JL; Ogboi, SJ; Ouedraogo, JB; Razafindralambo, L; Sagara, I; Scott, S; Snell, P; Sutherland, CJ; Traore, A; Zongo, I | 1 |
| Abio, H; Achan, J; Baker, K; Beinomugisha, G; Bonnington, C; Bwanika, JB; Kajubi, R; Kyagulanyi, T; Magumba, G; Marasciulo-Rice, M; Nabakooza, J; Nakirunda, M; Nuwa, A; Odong, DS; Odongo, M; Opigo, J; Rassi, C; Richardson, S; Rubahika, D; Rutazaana, D; Tibenderana, J | 1 |
| Aweeka, F; Conrad, MD; Haro, A; Huang, L; Legac, J; Ouédraogo, JB; Roh, ME; Rosenthal, PJ; Somé, AF; Wallender, E; Yerbanga, RS; Zongo, I | 1 |
26 review(s) available for sulfadoxine and amodiaquine
| Article | Year |
|---|---|
Current progress in antimalarial pharmacotherapy and multi-target drug discovery.
Topics: Animals; Antimalarials; Artemisinins; Drug Discovery; Drug Resistance; Humans; Malaria; Molecular Structure; Paclitaxel; Quinolines | 2020 |
[Current information on treatment and prophylaxis of malaria (author's transl)].
Topics: Adolescent; Adult; Amodiaquine; Child; Child, Preschool; Chloroquine; Dose-Response Relationship, Drug; Female; Humans; Infant; Insect Repellents; Malaria; Male; Plasmodium falciparum; Plasmodium malariae; Plasmodium vivax; Pregnancy; Pyrimethamine; Quinine; Sulfadiazine; Sulfadoxine; Tetracycline | 1979 |
Ascertainment of risk of serious adverse reactions associated with chemoprophylactic antimalarial drugs.
Topics: Amodiaquine; Antimalarials; Clinical Trials as Topic; Dapsone; Dose-Response Relationship, Drug; Drug Combinations; Humans; Product Surveillance, Postmarketing; Pyrimethamine; Sulfadoxine | 1990 |
Malaria chemoprophylaxis: an update.
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Child, Preschool; Dapsone; Drug Combinations; Female; Humans; Malaria; Proguanil; Pyrimethamine; Sulfadoxine | 1987 |
The chemoprophylaxis of malaria.
Topics: Amodiaquine; Animals; Chloroquine; Dapsone; Drug Combinations; Drug Resistance; Malaria; Plasmodium falciparum; Proguanil; Pyrimethamine; Sulfadoxine | 1987 |
Pharmacokinetics of antimalarial drugs: their therapeutic and toxicological implications.
Topics: Adult; Amodiaquine; Animals; Antimalarials; Child; Chloroquine; Dapsone; Drug Combinations; Drug Resistance, Microbial; Half-Life; Humans; Kinetics; Male; Mefloquine; Mice; Plasmodium falciparum; Primaquine; Proguanil; Pyrimethamine; Quinine; Quinolines; Sulfadoxine; Sulfalene | 1985 |
Falciparum malaria: the urgent need for safe and effective drugs.
Topics: Amodiaquine; Anti-Bacterial Agents; Antimalarials; Dapsone; Drug Combinations; Humans; Malaria; Plasmodium falciparum; Pyrimethamine; Quinidine; Quinine; Sulfadoxine | 1983 |
Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine as a treatment for uncomplicated malaria--a systematic review.
Topics: Amodiaquine; Antimalarials; Chloroquine; Drug Therapy, Combination; Humans; Malaria, Falciparum; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine | 1998 |
Comparative efficacy and safety of chloroquine and alternative antimalarial drugs: a meta-analysis from six African countries.
Topics: Africa, Eastern; Africa, Western; Amodiaquine; Antimalarials; Chloroquine; Drug Combinations; Drug Costs; Humans; Malaria; Mefloquine; Patient Selection; Phenanthrenes; Pyrimethamine; Quinine; Safety; Sulfadoxine; Treatment Outcome | 1999 |
Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine for treating uncomplicated malaria.
Topics: Adult; Amodiaquine; Chloroquine; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Pyrimethamine; Sulfadoxine | 2000 |
Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine for treating uncomplicated malaria.
Topics: Adult; Amodiaquine; Chloroquine; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Pyrimethamine; Sulfadoxine | 2001 |
Amodiaquine for treating malaria.
Topics: Amodiaquine; Antimalarials; Chloroquine; Drug Combinations; Humans; Malaria, Falciparum; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine | 2003 |
[Combined antimalarial therapy using artemisinin].
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Doxycycline; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Plasmodium; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine | 2004 |
Malaria: uncomplicated, caused by Plasmodium falciparum.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Dapsone; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Mefloquine; Proguanil; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2005 |
Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine for treating uncomplicated malaria.
Topics: Adult; Amodiaquine; Chloroquine; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Pyrimethamine; Sulfadoxine | 2005 |
Sulfadoxine-pyrimethamine plus artesunate versus sulfadoxine-pyrimethamine plus amodiaquine for treating uncomplicated malaria.
Topics: Amodiaquine; Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Humans; Malaria, Falciparum; Pyrimethamine; Randomized Controlled Trials as Topic; Sesquiterpenes; Sulfadoxine | 2006 |
Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine for uncomplicated malaria: a systematic review.
Topics: Amodiaquine; Antimalarials; Chloroquine; Drug Combinations; Drug Therapy, Combination; Humans; Malaria, Falciparum; Pyrimethamine; Randomized Controlled Trials as Topic; Research Design; Risk Factors; Sulfadoxine; Treatment Failure | 2006 |
Amodiaquine combined with sulfadoxine/pyrimethamine versus artemisinin-based combinations for the treatment of uncomplicated falciparum malaria in Africa: a meta-analysis.
Topics: Africa; Amodiaquine; Artemisinins; Drug Combinations; Humans; Malaria, Falciparum; Multicenter Studies as Topic; Pyrimethamine; Randomized Controlled Trials as Topic; Sesquiterpenes; Sulfadoxine | 2007 |
Malaria.
Topics: Africa South of the Sahara; Amodiaquine; Animals; Anopheles; Antimalarials; Artemisinins; Artesunate; Asia, Southeastern; Chloroquine; Drug Administration Schedule; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Insecticide-Treated Bednets; Insecticides; Malaria; Malaria Vaccines; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Pregnancy; Pregnancy Complications, Infectious; Primary Prevention; Pyrimethamine; Quinine; Quinolines; Seasons; Sulfadoxine | 2014 |
Risk of drug resistance in Plasmodium falciparum malaria therapy-a systematic review and meta-analysis.
Topics: Amodiaquine; Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Risk; Sulfadoxine | 2017 |
Animal Embryotoxicity Studies of Key Non-Artemisinin Antimalarials and Use in Women in the First Trimester.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Drug Combinations; Female; Humans; Malaria; Malaria, Falciparum; Naphthyridines; Pregnancy; Pregnancy Trimester, First; Pyrimethamine; Quinine; Quinolines; Rabbits; Rats; Sulfadoxine; Teratogens | 2017 |
Efficacy and tolerability of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: a systematic review and individual patient data meta-analysis.
Topics: Amodiaquine; Anti-Bacterial Agents; Antimalarials; Artemisinins; Artesunate; Atovaquone; Clindamycin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Proguanil; Pyrimethamine; Quinine; Quinolines; Sulfadoxine | 2020 |
Malaria PK/PD and the Role Pharmacometrics Can Play in the Global Health Arena: Malaria Treatment Regimens for Vulnerable Populations.
Topics: Amodiaquine; Anti-HIV Agents; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child, Preschool; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Female; Global Health; HIV Infections; Humans; Malaria; Malnutrition; Mefloquine; Models, Biological; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Quinolines; Sulfadoxine; Vulnerable Populations | 2021 |
Intermittent preventive treatment for malaria in infants.
Topics: Africa South of the Sahara; Amodiaquine; Antimalarials; Artemisinins; Bias; Confidence Intervals; Disease Eradication; Drug Combinations; Endemic Diseases; Hospitalization; Humans; Infant; Malaria; Parasitemia; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Sulfadoxine | 2021 |
Effectiveness of seasonal malaria chemoprevention (SMC) treatments when SMC is implemented at scale: Case-control studies in 5 countries.
Topics: Africa, Western; Age Factors; Amodiaquine; Antimalarials; Case-Control Studies; Child, Preschool; Communicable Disease Control; Drug Combinations; Female; Humans; Incidence; Infant; Malaria, Falciparum; Male; Parasite Load; Plasmodium falciparum; Program Evaluation; Pyrimethamine; Risk Assessment; Risk Factors; Seasons; Sulfadoxine; Time Factors; Treatment Outcome | 2021 |
Pharmacokinetic considerations in seasonal malaria chemoprevention.
Topics: Amodiaquine; Antimalarials; Chemoprevention; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria; Pregnancy; Pyrimethamine; Seasons; Sulfadoxine | 2022 |
119 trial(s) available for sulfadoxine and amodiaquine
| Article | Year |
|---|---|
Parasitological, clinical and haematological response of children with Plasmodium falciparum to 4-aminoquinolines and to pyrimethamine-sulfadoxine with quinine in western Kenya.
Topics: Amodiaquine; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Erythrocyte Count; Female; Hematocrit; Hemoglobins; Hospitals; Humans; Infant; Kenya; Malaria, Falciparum; Male; Pyrimethamine; Quinine; Reticulocytes; Seroepidemiologic Studies; Sulfadoxine | 1992 |
Evaluation of the relative efficacy of various antimalarial drugs in Nigerian children under five years of age suffering from acute uncomplicated falciparum malaria.
Topics: Acute Disease; Amodiaquine; Antimalarials; Child, Preschool; Chloroquine; Drug Administration Schedule; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Mefloquine; Nigeria; Pyrimethamine; Quinine; Sulfadoxine | 1992 |
Falciparum malaria fully cleared by amodiaquine, pyrimethamine-sulfadoxine and pyrimethamine-sulfalene in areas of chloroquine resistance in Dodoma, Tanzania.
Topics: Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Pyrimethamine; Sulfadoxine; Sulfalene; Tanzania; Time Factors | 1991 |
[Comparative study of sulfadoxine-pyrimethamine and amodiaquine + sulfadoxine-pyrimethamine for the treatment of malaria caused by chloroquine-resistant Plasmodium falciparum in Maputo, Mozambique].
Topics: Adult; Amodiaquine; Animals; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Hemoglobins; Humans; Leukocyte Count; Malaria; Mozambique; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 1990 |
Effectiveness of amodiaquine, sulfadoxine-pyrimethamine, and combinations of these drugs for treating chloroquine-resistant falciparum malaria in Hainan Island, China.
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria; Male; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 1988 |
A comparative trial of three regimens for treating uncomplicated falciparum malaria in Acre, Brazil.
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Brazil; Clindamycin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Malaria; Male; Plasmodium falciparum; Pyrimethamine; Quinine; Random Allocation; Sulfadoxine | 1988 |
[Efficacy of amodiaquine, Fansidar and their combination in the treatment of chloroquine-resistant falciparum malaria].
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Chloroquine; Double-Blind Method; Drug Combinations; Drug Resistance; Humans; Malaria; Plasmodium falciparum; Pyrimethamine; Random Allocation; Sulfadoxine; Sulfanilamides | 1988 |
[In vivo resistance of Plasmodium falciparum to 4-aminoquinolines and to a sulfadoxine-pyrimethamine combination. II. Study of Manaus, Amazonas 1983-1984].
Topics: Adolescent; Adult; Amodiaquine; Animals; Brazil; Chloroquine; Clinical Trials as Topic; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Random Allocation; Sulfadoxine; Sulfanilamides | 1986 |
Amodiaquine and sulfadoxine-pyrimethamine as treatment for chloroquine-resistant Plasmodium falciparum in Rwanda.
Topics: Amodiaquine; Animals; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria; Male; Plasmodium falciparum; Pyrimethamine; Rwanda; Sulfadoxine; Sulfanilamides | 1988 |
Evaluation of four therapeutic regimens for falciparum malaria in Mozambique, 1986.
Topics: Amodiaquine; Animals; Antimalarials; Child; Chloroquine; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Mozambique; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 1988 |
Effects of antimalarial agents on plasma levels of chlorpromazine and its metabolites in schizophrenic patients.
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Chloroquine; Chlorpromazine; Drug Combinations; Drug Synergism; Female; Humans; Male; Middle Aged; Pyrimethamine; Random Allocation; Schizophrenia; Sulfadoxine | 1988 |
Effects of chloroquine, amodiaquine and pyrimethamine-sulfadoxine on Plasmodium falciparum gametocytemia.
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Humans; Malaria; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides; Time Factors | 1986 |
Effectiveness of amodiaquine as treatment for chloroquine-resistant Plasmodium falciparum infections in Kenya.
Topics: Adolescent; Amodiaquine; Blood; Child; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Female; Follow-Up Studies; Humans; Kenya; Malaria; Male; Plasmodium falciparum; Pyrimethamine; Recurrence; Sulfadoxine | 1984 |
Response of Plasmodium falciparum to chloroquine and Fansidar in vivo and chloroquine and amodiaquine in vitro in Uganda.
Topics: Amodiaquine; Animals; Antimalarials; Child; Chloroquine; Drug Combinations; Drug Evaluation, Preclinical; Drug Resistance; Drug Therapy, Combination; Follow-Up Studies; Humans; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Uganda | 1995 |
In vivo sensitivity of Plasmodium falciparum to chloroquine, amodiaquine and sulfadoxine-pyrimethamine in western Uganda.
Topics: Adult; Amodiaquine; Animals; Antimalarials; Child; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Microbial Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Uganda | 1994 |
Response of falciparum malaria to chloroquine and three second line antimalarial drugs in a Kenyan coastal school age population.
Topics: Adolescent; Amodiaquine; Child; Chloroquine; Drug Combinations; Drug Resistance; Humans; Kenya; Malaria, Falciparum; Microbial Sensitivity Tests; Pyrimethamine; Rural Health; Sulfadoxine; Sulfalene | 1993 |
Resistance of Plasmodium falciparum to antimalarial drugs in Equatorial Guinea.
Topics: Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Equatorial Guinea; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1993 |
A randomized trial of chloroquine, amodiaquine and pyrimethamine-sulphadoxine in Gambian children with uncomplicated malaria.
Topics: Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Follow-Up Studies; Gambia; Hematocrit; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Rural Health; Sulfadoxine; Treatment Failure | 1996 |
A randomised controlled trial to assess the relative efficacy of chloroquine, amodiaquine, halofantrine and Fansidar in the treatment of uncomplicated malaria in children.
Topics: Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Phenanthrenes; Pyrimethamine; Sulfadoxine; Treatment Outcome | 1996 |
In vivo efficacy study of amodiaquine and sulfadoxine/ pyrimethamine in Kibwezi, Kenya and Kigoma, Tanzania.
Topics: Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Drug Resistance, Microbial; Female; Fever; Humans; Infant; Kenya; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tanzania; Treatment Outcome | 2000 |
Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial.
Topics: Adolescent; Amodiaquine; Antimalarials; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Pyrimethamine; Sulfadoxine; Time Factors; Treatment Outcome; Uganda | 2001 |
Gametocytaemia in Senegalese children with uncomplicated falciparum malaria treated with chloroquine, amodiaquine or sulfadoxine + pyrimethamine.
Topics: Adolescent; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Resistance; Drug Therapy, Combination; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Senegal; Sulfadoxine | 2001 |
Cardiac effects of amodiaquine and sulfadoxine-pyrimethamine in malaria-infected African patients.
Topics: Administration, Oral; Adolescent; Adult; Amodiaquine; Antimalarials; Bradycardia; Cameroon; Drug Administration Schedule; Drug Combinations; Electrocardiography; Female; Heart Rate; Humans; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Sulfadoxine | 2001 |
A randomized comparison of chloroquine, amodiaquine and their combination with pyrimethamine-sulfadoxine in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children.
Topics: Acute Disease; Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Therapy, Combination; Gametogenesis; Humans; Infant; Malaria, Falciparum; Pyrimethamine; Recurrence; Sulfadoxine; Treatment Failure; Treatment Outcome | 2002 |
Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon.
Topics: Administration, Oral; Amodiaquine; Antimalarials; Cameroon; Child; Child, Preschool; Drug Administration Schedule; Drug Combinations; Drug Monitoring; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Hematocrit; Humans; Malaria, Falciparum; Male; Parasitic Sensitivity Tests; Pyrimethamine; Sulfadoxine; Time Factors; Treatment Outcome | 2002 |
The safety and efficacy of sulfadoxine-pyrimethamine, amodiaquine, and their combination in the treatment of uncomplicated Plasmodium falciparum malaria.
Topics: Amodiaquine; Animals; Antimalarials; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2002 |
Combination of drug level measurement and parasite genotyping data for improved assessment of amodiaquine and sulfadoxine-pyrimethamine efficacies in treating Plasmodium falciparum malaria in Gabonese children.
Topics: Amodiaquine; Animals; Child; Child, Preschool; Drug Combinations; Female; Gabon; Genotype; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2003 |
Comparative efficacy of aminoquinoline-antifolate combinations for the treatment of uncomplicated falciparum malaria in Kampala, Uganda.
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Single-Blind Method; Sulfadoxine; Treatment Outcome; Uganda | 2003 |
[Efficacy of amodiaquine and sulfadoxine/pyrimethamine in the treatment of malaria not complicated by Plasmodium falciparum in Nariño, Colombia, 1999-2002].
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Child; Child, Preschool; Colombia; Drug Combinations; Female; Humans; Malaria; Male; Middle Aged; Pyrimethamine; Sulfadoxine; Treatment Failure | 2003 |
A randomized comparison of chloroquine and chloroquine plus ketotifen in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children.
Topics: Acute Disease; Administration, Oral; Amodiaquine; Analysis of Variance; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant; Ketotifen; Malaria, Falciparum; Male; Pyrimethamine; Recurrence; Sulfadoxine; Treatment Outcome | 2003 |
Plasmodium falciparum gametocytaemia in Nigerian children: before, during and after treatment with antimalarial drugs.
Topics: Age Factors; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2003 |
Efficacy of chloroquine, amodiaquine, sulphadoxine-pyrimethamine and combination therapy with artesunate in Mozambican children with non-complicated malaria.
Topics: Amodiaquine; Animals; Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Mozambique; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2004 |
Efficacy of sulphadoxine-pyrimethamine alone or combined with amodiaquine or chloroquine for the treatment of uncomplicated falciparum malaria in Ugandan children.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Therapy, Combination; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome; Uganda | 2004 |
Antimalarial efficacy of sulfadoxine-pyrimethamine, amodiaquine and a combination of chloroquine plus sulfadoxine-pyrimethamine in Bundi Bugyo, western Uganda.
Topics: Amodiaquine; Antimalarials; Child, Preschool; Chloroquine; Developing Countries; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome; Uganda | 2004 |
Efficacy of chloroquine, sulphadoxine-pyrimethamine and amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria in Kajo Keji county, Sudan.
Topics: Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Sudan; Sulfadoxine; Treatment Outcome | 2004 |
Risk factors for gametocyte carriage in uncomplicated falciparum malaria in children.
Topics: Amodiaquine; Animals; Antimalarials; Carrier State; Child; Child, Preschool; Chloroquine; Chlorpheniramine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Nigeria; Parasitemia; Plasmodium falciparum; Prospective Studies; Pyrimethamine; Regression Analysis; Risk Factors; Sulfadoxine | 2004 |
Plasmodium falciparum hyperparasitaemia in children. Risk factors, treatment outcomes, and gametocytaemia following treatment.
Topics: Age Factors; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Gametogenesis; Humans; Malaria, Falciparum; Male; Nigeria; Parasitemia; Plasmodium falciparum; Prospective Studies; Pyrimethamine; Risk Factors; Sulfadoxine; Treatment Failure; Treatment Outcome | 2004 |
Comparison of the parasitologic efficacy of amodiaquine and sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria in the Bungoma District of western Kenya.
Topics: Amodiaquine; Animals; Antimalarials; Drug Administration Schedule; Drug Combinations; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Infant; Kenya; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2004 |
Evidence basis for antimalarial policy change in Sierra Leone: five in vivo efficacy studies of chloroquine, sulphadoxine-pyrimethamine and amodiaquine.
Topics: Amodiaquine; Animals; Antimalarials; Child, Preschool; Chloroquine; Developing Countries; Drug Combinations; Drug Resistance; Evidence-Based Medicine; Female; Health Policy; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sierra Leone; Sulfadoxine; Treatment Failure; Treatment Outcome | 2005 |
A randomized comparative study of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Ghana.
Topics: Amodiaquine; Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Female; Fever; Ghana; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Patient Dropouts; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome | 2005 |
Efficacy of two artemisinin combination therapies for uncomplicated falciparum malaria in children under 5 years, Malakal, Upper Nile, Sudan.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Sesquiterpenes; Sudan; Sulfadoxine | 2005 |
Malaria in the Nuba Mountains of Sudan: baseline genotypic resistance and efficacy of the artesunate plus sulfadoxine-pyrimethamine and artesunate plus amodiaquine combinations.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Membrane Proteins; Membrane Transport Proteins; Protozoan Proteins; Pyrimethamine; Sesquiterpenes; Sudan; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2005 |
Antimalarial efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, and the combinations of amodiaquine + artesunate and sulfadoxine-pyrimethamine + artesunate in Huambo and Bie provinces, central Angola.
Topics: Amodiaquine; Angola; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Failure | 2005 |
Sulfadoxine-pyrimethamine plus chloroquine or amodiaquine for uncomplicated falciparum malaria: a randomized, multisite trial to guide national policy in Uganda.
Topics: Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Health Policy; Humans; Infant; Malaria, Falciparum; Pyrimethamine; Sulfadoxine; Uganda | 2005 |
A randomized, placebo-controlled, double-blind trial on sulfadoxine-pyrimethamine alone or combined with artesunate or amodiaquine in uncomplicated malaria.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Genotype; Humans; Infant; Malaria, Falciparum; Male; Parasite Egg Count; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2005 |
Efficacy of combination therapy with artesunate plus amodiaquine compared to monotherapy with chloroquine, amodiaquine or sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum in Afghanistan.
Topics: Adolescent; Adult; Afghanistan; Aged; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Parasite Egg Count; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Failure; Treatment Outcome | 2005 |
Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda.
Topics: Amodiaquine; Antimalarials; Artemisinins; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Genotype; Humans; Infant; Infections; Malaria; Male; Pyrimethamine; Risk Factors; Sesquiterpenes; Sulfadoxine; Treatment Outcome; Uganda | 2005 |
Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Ghana; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2005 |
Therapeutic efficacy of sulfadoxine-pyrimethamine and amodiaquine among children with uncomplicated Plasmodium falciparum malaria in Zanzibar, Tanzania.
Topics: Amodiaquine; Anemia; Animals; Antimalarials; Child, Preschool; Drug Combinations; Drug Resistance; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tanzania; Treatment Failure; Treatment Outcome | 2005 |
Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Parasitemia; Polymerase Chain Reaction; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Failure; Treatment Outcome | 2005 |
[Evaluation of the therapeutic efficacy of amodiaquine versus chloroquine in the treatment of uncomplicated malaria in Abie, Côte-d'Ivoire].
Topics: Amodiaquine; Animals; Antimalarials; Child, Preschool; Chloroquine; Cote d'Ivoire; Drug Combinations; Drug Resistance, Multiple; Endemic Diseases; Female; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2005 |
Amodiaquine, sulfadoxine-pyrimethamine, and combination therapy for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso.
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Burkina Faso; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2005 |
Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance.
Topics: Adolescent; Adult; Aged; Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Endemic Diseases; Geography; Humans; Infant; Malaria, Falciparum; Membrane Proteins; Membrane Transport Proteins; Middle Aged; Mutation, Missense; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Failure; Treatment Outcome; Uganda | 2006 |
Tolerability of amodiaquine and sulphadoxine-pyrimethamine, alone or in combination for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan adults.
Topics: Adult; Amodiaquine; Antimalarials; Blood Cell Count; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Fatigue; Female; Hematocrit; Humans; Malaria, Falciparum; Male; Neutropenia; Pruritus; Pyrimethamine; Rwanda; Sulfadoxine; Treatment Outcome | 2006 |
Antischistosomal efficacy of artesunate combination therapies administered as curative treatments for malaria attacks.
Topics: Amodiaquine; Animals; Anthelmintics; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Humans; Infant; Malaria; Pilot Projects; Pyrimethamine; Schistosoma haematobium; Schistosomiasis haematobia; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2007 |
Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Democratic Republic of the Congo; DNA, Protozoan; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Haplotypes; Humans; Infant; Malaria; Malaria, Falciparum; Male; Plasmodium; Polymerase Chain Reaction; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2006 |
A randomised trial to assess the safety and efficacy of artemether-lumefantrine (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwanda.
Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fever; Fluorenes; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2007 |
Efficacy, safety, and tolerability of amodiaquine plus sulphadoxine-pyrimethamine used alone or in combination for malaria treatment in pregnancy: a randomised trial.
Topics: Adult; Amodiaquine; Antimalarials; Chloroquine; Drug Administration Schedule; Drug Combinations; Female; Ghana; Humans; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2006 |
Improved efficacy with amodiaquine instead of chloroquine in sulfadoxine/pyrimethamine combination treatment of falciparum malaria in Uganda: experience with fixed-dose formulation.
Topics: Amodiaquine; Animals; Antimalarials; Child, Preschool; Chloroquine; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome; Uganda | 2006 |
Efficacies of artesunate plus either sulfadoxine-pyrimethamine or amodiaquine, for the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Humans; Malaria, Falciparum; Parasitemia; Pyrimethamine; Sesquiterpenes; Sudan; Sulfadoxine; Treatment Outcome | 2007 |
Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial.
Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Burkina Faso; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Male; Parasitemia; Pyrimethamine; Recurrence; Sulfadoxine; Treatment Outcome | 2007 |
Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zérékoré.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Genes, Protozoan; Genetic Markers; Genotype; Guinea; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2007 |
Randomized clinical trial of artemisinin versus non-artemisinin combination therapy for uncomplicated falciparum malaria in Madagascar.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Humans; Infant; Madagascar; Malaria, Falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2007 |
Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial.
Topics: Amodiaquine; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Infant; Longitudinal Studies; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Single-Blind Method; Sulfadoxine; Treatment Outcome; Uganda; Urban Population | 2007 |
Efficacy of artesunate plus amodiaquine, artesunate plus sulfadoxine-pyrimethamine, and chloroquine plus sulfadoxine-pyrimethamine in patients with uncomplicated Plasmodium falciparum in the Comoros Union.
Topics: Adolescent; Adult; Aged; Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Comoros; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2007 |
Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal.
Topics: Adolescent; Adult; Aged; Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Follow-Up Studies; Humans; Infant; Lumefantrine; Malaria, Falciparum; Mefloquine; Middle Aged; Plasmodium falciparum; Pyrimethamine; Senegal; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2007 |
Efficacy of sulfadoxine-pyrimethamine, amodiaquine, and sulfadoxine-pyrimethamine-amodiaquine combination for the treatment of uncomplicated falciparum malaria in the urban and suburban areas of Brazzaville (Congo).
Topics: Amodiaquine; Antimalarials; Carrier State; Child, Preschool; Congo; DNA, Protozoan; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2007 |
Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
Topics: Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Papua New Guinea; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Sulfadoxine | 2007 |
Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
Topics: Amodiaquine; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Burkina Faso; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine | 2007 |
Antimalarial resistance and DHFR/DHPS genotypes of Plasmodium falciparum three years after introduction of sulfadoxine-pyrimethamine and amodiaquine in rural Tanzania.
Topics: Amodiaquine; Animals; Antimalarials; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Follow-Up Studies; Genotype; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Point Mutation; Pyrimethamine; Rural Health; Sulfadoxine; Tanzania; Tetrahydrofolate Dehydrogenase; Treatment Failure | 2008 |
A trial of the efficacy, safety and impact on drug resistance of four drug regimens for seasonal intermittent preventive treatment for malaria in Senegalese children.
Topics: Amodiaquine; Antimalarials; Arsenites; Child; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Pyrimethamine; Seasons; Senegal; Sulfadoxine | 2008 |
Sulphadoxine/pyrimethamine versus amodiaquine for treating uncomplicated childhood malaria in Gabon: a randomized trial to guide national policy.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Dihydropteroate Synthase; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Gabon; Health Policy; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2008 |
Efficacy, safety, and selection of molecular markers of drug resistance by two ACTs in Mali.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Biomarkers; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mali; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Time Factors; Vomiting | 2008 |
Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children.
Topics: Amodiaquine; Anorexia; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Infant; Longitudinal Studies; Malaria, Falciparum; Muscle Weakness; Pyrimethamine; Single-Blind Method; Sulfadoxine; Uganda | 2008 |
Effect of intermittent preventive treatment of malaria on health and education in schoolchildren: a cluster-randomised, double-blind, placebo-controlled trial.
Topics: Adolescent; Amodiaquine; Anemia; Animals; Antimalarials; Child; Child, Preschool; Cluster Analysis; Cognition; Cross-Sectional Studies; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Feces; Female; Humans; Kenya; Malaria, Falciparum; Male; Plasmodium falciparum; Prevalence; Pyrimethamine; Sulfadoxine | 2008 |
[Efficacy of the amodiaquine+sulfadoxine-pyrimethamine combination and of chloroquine for the treatment of malaria in Córdoba, Colombia, 2006].
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Child; Chloroquine; Colombia; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Female; Humans; Malaria; Male; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome | 2008 |
[Gametocytemia in falciparum malaria treated with amodiaquine or artesunate].
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Colombia; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome | 2008 |
A randomized, controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana.
Topics: Amodiaquine; Anemia; Animals; Antimalarials; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Ghana; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria, Falciparum; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2008 |
dhfr and dhps genotype and sulfadoxine-pyrimethamine treatment failure in children with falciparum malaria in the Democratic Republic of Congo.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Democratic Republic of the Congo; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Genetic Markers; Genotype; Humans; Infant; Malaria, Falciparum; Male; Point Mutation; Pyrimethamine; Rural Health; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Failure | 2008 |
Seasonal intermittent preventive treatment for the prevention of anaemia and malaria in Ghanaian children: a randomized, placebo controlled trial.
Topics: Amodiaquine; Anemia; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Drug Combinations; Ghana; Humans; Infant; Kaplan-Meier Estimate; Malaria; Placebos; Pyrimethamine; Seasons; Sulfadoxine | 2008 |
High risk of severe anaemia after chlorproguanil-dapsone+artesunate antimalarial treatment in patients with G6PD (A-) deficiency.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Dapsone; Drug Combinations; Drug Therapy, Combination; Female; Glucosephosphate Dehydrogenase Deficiency; Humans; Infant; Malaria, Falciparum; Male; Oxidants; Polymorphism, Genetic; Proguanil; Pyrimethamine; Sulfadoxine | 2008 |
Artemisinin-based combinations versus amodiaquine plus sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje, Mali.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Mali; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Single-Blind Method; Sulfadoxine; Treatment Outcome | 2009 |
Decreasing efficacy of antimalarial combination therapy in Uganda is explained by decreasing host immunity rather than increasing drug resistance.
Topics: Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Infant; Longitudinal Studies; Malaria; Plasmodium; Pyrimethamine; Sulfadoxine; Treatment Failure; Uganda | 2009 |
Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali.
Topics: Amodiaquine; Animals; Antigens, Protozoan; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Genes, Protozoan; Genetic Markers; Genotype; Humans; Infant; Malaria, Falciparum; Male; Mali; Merozoite Surface Protein 1; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2009 |
Randomized trial of artesunate+amodiaquine, sulfadoxine-pyrimethamine+amodiaquine, chlorproguanal-dapsone and SP for malaria in pregnancy in Tanzania.
Topics: Adult; Amodiaquine; Artemisinins; Artesunate; Dapsone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Proguanil; Pyrimethamine; Sulfadoxine; Tanzania; Young Adult | 2009 |
Comparison of sulfadoxine-pyrimethamine, unsupervised artemether-lumefantrine, and unsupervised artesunate-amodiaquine fixed-dose formulation for uncomplicated plasmodium falciparum malaria in Benin: a randomized effectiveness noninferiority trial.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Benin; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Polymerase Chain Reaction; Pyrimethamine; Sulfadoxine | 2009 |
Varying efficacy of artesunate+amodiaquine and artesunate+sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in the Democratic Republic of Congo: a report of two in-vivo studies.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Democratic Republic of the Congo; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome | 2009 |
Options for the delivery of intermittent preventive treatment for malaria to children: a community randomised trial.
Topics: Amodiaquine; Antimalarials; Child, Preschool; Community Health Services; Drug Combinations; Female; Ghana; Home Care Services; Humans; Infant; Malaria, Falciparum; Male; Program Evaluation; Pyrimethamine; Seasons; Sulfadoxine; Treatment Outcome | 2009 |
Selection of parasites with diminished drug susceptibility by amodiaquine-containing antimalarial regimens in Uganda.
Topics: Amino Acid Sequence; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Cohort Studies; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Humans; Infant; Malaria, Falciparum; Molecular Sequence Data; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Genetic; Pyrimethamine; Sequence Alignment; Sulfadoxine; Uganda | 2009 |
Amodiaquine dosage and tolerability for intermittent preventive treatment to prevent malaria in children.
Topics: Age Factors; Amodiaquine; Antimalarials; Body Weight; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Humans; Infant; Malaria; Pyrimethamine; Seasons; Sulfadoxine; Treatment Outcome | 2010 |
Efficacy of amodiaquine, sulphadoxine-pyrimethamine and their combination for the treatment of uncomplicated Plasmodium falciparum malaria in children in Cameroon at the time of policy change to artemisinin-based combination therapy.
Topics: Administration, Oral; Amodiaquine; Antimalarials; Cameroon; Child, Preschool; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Monitoring; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Health Policy; Humans; Infant; Malaria, Falciparum; Male; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Time Factors; Treatment Outcome | 2010 |
Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon.
Topics: Administration, Oral; Amodiaquine; Antimalarials; Artemisinins; Cameroon; Child, Preschool; Drug Administration Schedule; Drug Combinations; Drug Monitoring; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant, Newborn; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Pyrimethamine; Regression Analysis; Sulfadoxine; Time Factors; Treatment Outcome | 2010 |
Incidence of malaria and efficacy of combination antimalarial therapies over 4 years in an urban cohort of Ugandan children.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Incidence; Infant; Lumefantrine; Malaria; Male; Pyrimethamine; Sulfadoxine; Treatment Outcome; Uganda | 2010 |
Cost effectiveness of seasonal intermittent preventive treatment using amodiaquine & artesunate or sulphadoxine-pyrimethamine in Ghanaian children.
Topics: Amodiaquine; Anemia; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Cost-Benefit Analysis; Drug Combinations; Ghana; Humans; Infant; Malaria; Preventive Health Services; Pyrimethamine; Seasons; Sulfadoxine | 2010 |
Influences of intermittent preventive treatment and persistent multiclonal Plasmodium falciparum infections on clinical malaria risk.
Topics: Amodiaquine; Antigens, Protozoan; Antimalarials; Child, Preschool; Cross-Sectional Studies; Drug Combinations; Ghana; Humans; Infant; Malaria, Falciparum; Placebos; Protozoan Proteins; Pyrimethamine; Risk Factors; Sulfadoxine | 2010 |
A trial of intermittent preventive treatment and home-based management of malaria in a rural area of The Gambia.
Topics: Amodiaquine; Antimalarials; Child, Preschool; Double-Blind Method; Drug Combinations; Female; Gambia; Humans; Incidence; Infant; Malaria; Male; Placebos; Pyrimethamine; Rural Population; Sulfadoxine; Treatment Outcome | 2011 |
Two strategies for the delivery of IPTc in an area of seasonal malaria transmission in the Gambia: a randomised controlled trial.
Topics: Amodiaquine; Antimalarials; Child; Child, Preschool; Drug Combinations; Female; Humans; Infant; Insecticide-Treated Bednets; Malaria; Male; Pyrimethamine; Sulfadoxine | 2011 |
Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Burkina Faso: a randomised, double-blind, placebo-controlled trial.
Topics: Amodiaquine; Antimalarials; Burkina Faso; Child, Preschool; Double-Blind Method; Drug Combinations; Humans; Infant; Insecticide-Treated Bednets; Malaria; Pyrimethamine; Sulfadoxine | 2011 |
Malaria morbidity in children in the year after they had received intermittent preventive treatment of malaria in Mali: a randomized control trial.
Topics: Amodiaquine; Anemia; Antimalarials; Body Weight; Child, Preschool; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Incidence; Infant; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Mali; Morbidity; Mosquito Nets; Parasitemia; Plasmodium falciparum; Prevalence; Pyrimethamine; Seasons; Sulfadoxine; Treatment Outcome | 2011 |
Morbidity from malaria in children in the year after they had received intermittent preventive treatment of malaria: a randomised trial.
Topics: Amodiaquine; Anemia; Antimalarials; Body Weight; Burkina Faso; Child, Preschool; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Incidence; Infant; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Morbidity; Mosquito Nets; Plasmodium falciparum; Prevalence; Pyrimethamine; Seasons; Sulfadoxine; Treatment Outcome | 2011 |
Effects of amodiaquine and artesunate on sulphadoxine-pyrimethamine pharmacokinetic parameters in children under five in Mali.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Blood Chemical Analysis; Child, Preschool; Drug Combinations; Drug Interactions; Female; Half-Life; Humans; Infant; Malaria; Male; Mali; Pyrimethamine; Sulfadoxine | 2011 |
Impact of combining intermittent preventive treatment with home management of malaria in children less than 10 years in a rural area of Senegal: a cluster randomized trial.
Topics: Amodiaquine; Anemia; Animals; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Community Health Workers; Disease Management; Drug Combinations; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Health Promotion; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Prevalence; Preventive Health Services; Pyrimethamine; Rural Population; Seasons; Senegal; Sulfadoxine | 2011 |
Efficacy of different primaquine-based antimalarial regimens against Plasmodium falciparum gametocytemia.
Topics: Adolescent; Adult; Aged; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Colombia; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Germ Cells; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Plasmodium falciparum; Primaquine; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2012 |
Intermittent preventive treatment for malaria in Papua New Guinean infants exposed to Plasmodium falciparum and P. vivax: a randomized controlled trial.
Topics: Amodiaquine; Antimalarials; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Malaria; Male; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Sulfadoxine | 2012 |
Repeated artemisinin-based combination therapies in a malaria hyperendemic area of Mali: efficacy, safety, and public health impact.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Malaria; Male; Mali; Pyrimethamine; Sulfadoxine | 2012 |
Good efficacy of artemether-lumefantrine for uncomplicated falciparum malaria in eastern Sumba, East Nusatenggara, Indonesia.
Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Fluorenes; Humans; Indonesia; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Recurrence; Sulfadoxine; Time Factors | 2012 |
Artesunate/amodiaquine malaria treatment for Equatorial Guinea (Central Africa).
Topics: Amodiaquine; Artemisinins; Child, Preschool; DNA, Protozoan; Drug Combinations; Equatorial Guinea; Female; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Failure; World Health Organization | 2013 |
Host candidate gene polymorphisms and associated clearance of P. falciparum amodiaquine and fansidar resistance mutants in children less than 5 years in Cameroon.
Topics: Amodiaquine; Antimalarials; Cameroon; Child, Preschool; Drug Combinations; Drug Resistance; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Infant; Infant, Newborn; Interleukin-22; Interleukin-4; Interleukins; Malaria, Falciparum; Male; Plasmodium falciparum; Polymorphism, Single Nucleotide; Pyrimethamine; Sulfadoxine | 2014 |
Efficacy of sulphadoxine-pyrimethamine + artesunate, sulphadoxine-pyrimethamine + amodiaquine, and sulphadoxine-pyrimethamine alone in uncomplicated falciparum malaria in Mali.
Topics: Amodiaquine; Antimalarials; Artemisinins; Child, Preschool; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Mali; Pyrimethamine; Sulfadoxine | 2015 |
Randomized Noninferiority Trial of Dihydroartemisinin-Piperaquine Compared with Sulfadoxine-Pyrimethamine plus Amodiaquine for Seasonal Malaria Chemoprevention in Burkina Faso.
Topics: Amodiaquine; Antimalarials; Artemisinins; Burkina Faso; Case-Control Studies; Chemoprevention; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant; Malaria; Male; Pyrimethamine; Quinolines; Seasons; Sulfadoxine | 2015 |
The effect of iron-fortified complementary food and intermittent preventive treatment of malaria on anaemia in 12- to 36-month-old children: a cluster-randomised controlled trial.
Topics: Amodiaquine; Anemia; Antimalarials; Child, Preschool; Cote d'Ivoire; Diphosphates; Drug Combinations; Edetic Acid; Ferric Compounds; Food, Fortified; Hemoglobins; Humans; Infant; Inflammation; Iron; Iron Deficiencies; Malaria; Male; Prevalence; Pyrimethamine; Sulfadoxine | 2015 |
Seasonal malaria chemoprevention in an area of extended seasonal transmission in Ashanti, Ghana: an individually randomised clinical trial.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Chemoprevention; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Ghana; Humans; Infant; Infant, Newborn; Lumefantrine; Malaria; Male; Pyrimethamine; Quinolines; Rain; Seasons; Sulfadoxine | 2016 |
Safety of Seasonal Malaria Chemoprevention (SMC) with Sulfadoxine-Pyrimethamine plus Amodiaquine when Delivered to Children under 10 Years of Age by District Health Services in Senegal: Results from a Stepped-Wedge Cluster Randomized Trial.
Topics: Amodiaquine; Antimalarials; Chemoprevention; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Health Services; Hospitalization; Humans; Infant; Jaundice; Malaria; Male; Pyrimethamine; Seasons; Senegal; Sulfadoxine; Survival Analysis | 2016 |
Effectiveness of Seasonal Malaria Chemoprevention in Children under Ten Years of Age in Senegal: A Stepped-Wedge Cluster-Randomised Trial.
Topics: Amodiaquine; Antimalarials; Chemoprevention; Child; Child, Preschool; Drug Combinations; Humans; Infant; Malaria; Pyrimethamine; Seasons; Senegal; Sulfadoxine | 2016 |
Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trial.
Topics: Adolescent; Adult; Amodiaquine; Artemisinins; Child; Child, Preschool; Drug Combinations; Humans; Malaria, Falciparum; Mali; Methylene Blue; Middle Aged; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinolines; Sulfadoxine; Young Adult | 2018 |
Effect of seasonal malaria chemoprevention plus azithromycin on Plasmodium falciparum transmission: gametocyte infectivity and mosquito fitness.
Topics: Amodiaquine; Animals; Antimalarials; Azithromycin; Chemoprevention; Child, Preschool; Culicidae; Drug Combinations; Genetic Fitness; Humans; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Seasons; Sulfadoxine | 2021 |
Overall and Gender-Specific Effects of Intermittent Preventive Treatment of Malaria with Artemisinin-Based Combination Therapies among Schoolchildren in Mali: A Three-Group Open Label Randomized Controlled Trial.
Topics: Amodiaquine; Anemia; Antimalarials; Artemisinins; Artesunate; Child; Drug Combinations; Drug Therapy, Combination; Female; Hemoglobins; Humans; Malaria; Malaria, Falciparum; Mali; Pyrimethamine; Sulfadoxine | 2022 |
Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial.
Topics: Amodiaquine; Anemia, Sickle Cell; Antimalarials; Artemisinins; Chemoprevention; Child; Child, Preschool; Drug Combinations; Female; Humans; Hydroxyurea; Infant; Kenya; Malaria; Malaria, Falciparum; Male; Proguanil; Pyrimethamine; Sulfadoxine | 2022 |
A non-randomized controlled trial to assess the protective effect of SMC in the context of high parasite resistance in Uganda.
Topics: Amodiaquine; Animals; Antimalarials; Chemoprevention; Child; Drug Combinations; Humans; Infant; Malaria; Parasites; Prospective Studies; Seasons; Sulfadoxine; Uganda | 2023 |
119 other study(ies) available for sulfadoxine and amodiaquine
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Novel Antimalarial Tetrazoles and Amides Active against the Hemoglobin Degradation Pathway in
Topics: Amides; Antimalarials; Drug Resistance, Microbial; Hemeproteins; Hemoglobins; Hep G2 Cells; Humans; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Small Molecule Libraries; Structure-Activity Relationship; Tetrazoles | 2021 |
[Chemotherapy and chemoprophylaxis of malaria (author's transl)].
Topics: Adult; Amodiaquine; Antimalarials; Asia, Southeastern; Central America; Child; Chloroquine; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Malaria; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Quinine; Sulfadoxine; Sulfalene; Travel | 1976 |
Sensitivity status of Plasmodium falciparum to chloroquine, amodiaquine, quinine, mefloquine and sulfadoxine/pyrimethamine in a tribal population of District Sundargarh, Orissa.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; India; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1992 |
Treatment of chloroquine-resistant malaria in African children: a cost-effectiveness analysis.
Topics: Africa; Amodiaquine; Animals; Antimalarials; Child, Preschool; Chloroquine; Cost-Benefit Analysis; Decision Trees; Drug Combinations; Drug Costs; Drug Resistance; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 1992 |
Drug use and design in the nineties.
Topics: Aminoquinolines; Amodiaquine; Antimalarials; Artemisinins; Calcium Channel Blockers; Chloroquine; Humans; Malaria; Mefloquine; Naphthoquinones; Phenanthrenes; Primaquine; Quinine; Sesquiterpenes; Sulfadoxine | 1991 |
[Prevention and treatment of malaria in expatriates living in Black Africa. Influence of chemoresistance. Investigations conducted in Brazzaville (Congo)].
Topics: Adolescent; Adult; Aged; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Congo; Drug Combinations; Drug Resistance, Microbial; Europe; Humans; Infant; Infant, Newborn; Malaria; Mefloquine; Middle Aged; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1991 |
Resistance to antimalarials by Plasmodium falciparum in Arso PIR, Irian Jaya, Indonesia.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Indonesia; Malaria; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1991 |
Serious adverse drug reactions to pyrimethamine-sulphadoxine, pyrimethamine-dapsone and to amodiaquine in Britain.
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Dapsone; Drug Combinations; Drug Eruptions; Female; Hematologic Diseases; Humans; Male; Middle Aged; Pyrimethamine; Retrospective Studies; Sulfadoxine; Sulfanilamides | 1990 |
[Plasmodium falciparum drug resistance in the Congo. Evaluation of surveys carried out from 1985 to 1989].
Topics: Adolescent; Aminoquinolines; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Congo; Drug Combinations; Drug Resistance; Humans; Infant; Malaria; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1990 |
Prophage induction by 4 antimalaria drugs (daraprim, fansidar, nivaquine and camoquine) and in combination with aflatoxin B1.
Topics: Aflatoxin B1; Aflatoxins; Amodiaquine; Antimalarials; Chloroquine; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Escherichia coli; In Vitro Techniques; Lysogeny; Mutagenicity Tests; Pyrimethamine; Sulfadoxine | 1989 |
Curative and preventive treatment of uncomplicated malaria in public health institutions in Cameroon.
Topics: Amodiaquine; Antimalarials; Cameroon; Child; Chloroquine; Drug Combinations; Female; Humans; Malaria; Medicine; Nurses; Physicians; Pregnancy; Public Health; Pyrimethamine; Quinine; Specialization; Sulfadoxine; Surveys and Questionnaires | 1989 |
Serial studies on the evolution of drug resistance in malaria in an area of east Africa: findings from 1979 up to 1986.
Topics: Age Factors; Amodiaquine; Animals; Antibodies, Protozoan; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Resistance; Drug Therapy, Combination; Humans; Infant; Malaria; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinidine; Quinine; Quinolines; Sulfadoxine; Tanzania | 1988 |
Antagonism of chloroquine with other antimalarials.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Drug Interactions; Drug Resistance; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Quinolines; Sesquiterpenes; Sulfadoxine | 1988 |
Multiple drug resistant Plasmodium falciparum malaria in a pregnant indigenous Zambian woman.
Topics: Adult; Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Erythromycin; Female; Humans; Malaria; Mefloquine; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Quinine; Quinolines; Sulfadoxine | 1988 |
Agranulocytosis associated with the use of amodiaquine for malaria prophylaxis.
Topics: Agranulocytosis; Amodiaquine; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Proguanil; Pyrimethamine; Sulfadoxine; Travel | 1986 |
Amodiaquine induced agranulocytosis: inhibition of colony growth in bone marrow by antimalarial agents.
Topics: Adult; Agranulocytosis; Amodiaquine; Antimalarials; Bone Marrow; Bone Marrow Cells; Cells, Cultured; Chloroquine; Female; Granulocytes; Humans; Macrophages; Sulfadoxine | 1986 |
[Pharmacoresistance of Plasmodium falciparum in Rwanda: an in vivo study].
Topics: Amodiaquine; Animals; Chloroquine; Drug Resistance, Microbial; Humans; Plasmodium falciparum; Pyrimethamine; Rwanda; Sulfadoxine | 1987 |
[2 cases of multiresistant Plasmodium falciparum malaria contracted in Douala with atypical clinical presentation].
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Cameroon; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine | 1987 |
[Development of drug resistance in cases of P. falciparum malaria of African origin in a Parisian hospital. Comparison with field data and therapeutic consequences].
Topics: Africa; Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; France; Humans; Malaria; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Travel | 1987 |
Comparative efficacy of alternative primary therapies for Plasmodium falciparum infections in Malawi.
Topics: Amodiaquine; Animals; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria; Malawi; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1987 |
Sensitivity of Plasmodium falciparum to antimalarial drugs in Colombia.
Topics: Amodiaquine; Antimalarials; Chloroquine; Colombia; Drug Combinations; Drug Resistance, Microbial; Geography; Humans; Malaria; Mefloquine; Microbial Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine | 1985 |
Malaria prophylaxis for Canadian travellers.
Topics: Amodiaquine; Canada; Chloroquine; Dapsone; Doxycycline; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Infant; Infant, Newborn; Malaria; Plasmodium; Plasmodium falciparum; Pregnancy; Premedication; Proguanil; Pyrimethamine; Quinine; Sulfadoxine; Travel | 1985 |
Drug-resistant malaria--changing patterns mean difficult decisions.
Topics: Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Resistance, Microbial; Humans; Infant; Kenya; Malaria; Microbial Sensitivity Tests; Plasmodium; Plasmodium falciparum; Proguanil; Pyrimethamine; Quinine; Sulfadoxine | 1985 |
Management of Plasmodium falciparum malaria.
Topics: Amodiaquine; Anemia; Antimalarials; Brain Diseases; Chloroquine; Drug Resistance; Female; Humans; Hypoglycemia; Malaria; Oliguria; Pregnancy; Pregnancy Complications, Infectious; Pulmonary Edema; Pyrimethamine; Quinine; Sulfadoxine | 1984 |
Acute malaria in children in Madang: endemicity, clinical presentation and treatment.
Topics: Amodiaquine; Child, Preschool; Chloroquine; Drug Resistance; Humans; Malaria; Papua New Guinea; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 1981 |
In vitro susceptibility of Plasmodium falciparum to chloroquine, amodiaquine, quinine, mefloquine, and sulfadoxine/pyrimethamine in Equatorial Guinea.
Topics: Amodiaquine; Animals; Antimalarials; Child; Chloroquine; Drug Combinations; Equatorial Guinea; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Regression Analysis; Sulfadoxine | 1995 |
Sensitivity to antimalarial drugs by Plasmodium falciparum in Goundry, Oubritenga province, Burkina Faso.
Topics: Amodiaquine; Animals; Antimalarials; Burkina Faso; Child; Child, Preschool; Chloroquine; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; National Health Programs; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 1994 |
[In vitro sensitivity of Plasmodium falciparum to mefloquine, quinine, amodiaquine, chloroquine, pyronaridine and sulfadoxine/pyrimethamine in south Yunnan].
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Mefloquine; Naphthyridines; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1994 |
Assessment of the response in vivo and in vitro of Plasmodium falciparum to sulphadoxine-pyrimethamine in the malarious areas of Iran.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amodiaquine; Animals; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant; Iran; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Quinine; Regression Analysis; Sulfadoxine | 1993 |
Chemoresistance of Plasmodium falciparum in the urban region of Yaounde, Cameroon. Part 2: Evaluation of the efficacy of amodiaquine and sulfadoxine-pyrimethamine combination in the treatment of uncomplicated Plasmodium falciparum malaria in Yaounde, Came
Topics: Adolescent; Adult; Aged; Amodiaquine; Animals; Antimalarials; Cameroon; Child; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome; Urban Health | 2000 |
[Resistance of Plasmodium falciparum to 3 antimalarials in Turbo (Antioquia, Colombia), 1998].
Topics: Adolescent; Adult; Aged; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Colombia; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2001 |
[In vivo sensitivity of Plasmodium falciparum to amino-4-quinolines and sulfadoxine pyrimethamine in Agou (Ivory Coast)].
Topics: Adolescent; Aminoquinolines; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Cote d'Ivoire; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Infant; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2002 |
Resistance of Plamodium falciparum to antimalarial drugs in Zaragoza (Antioquia, Colombia), 1998.
Topics: Adolescent; Amodiaquine; Animals; Antimalarials; Chloroquine; Colombia; Drug Resistance; Humans; Male; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2002 |
Molecular epidemiology of malaria in Cameroon. X. Evaluation of PFMDR1 mutations as genetic markers for resistance to amino alcohols and artemisinin derivatives.
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Base Sequence; Cameroon; Child; Child, Preschool; Chloroquine; DNA Primers; Drug Combinations; Drug Resistance, Multiple; Genetic Markers; Humans; Malaria, Falciparum; Molecular Epidemiology; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sulfadoxine | 2002 |
Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum must be delayed in Africa.
Topics: Africa; Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2002 |
Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp.
Topics: Amodiaquine; Animals; Antigens, Protozoan; Antimalarials; Artemisinins; Artesunate; Child, Preschool; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Infant; Longitudinal Studies; Malaria, Falciparum; Male; Merozoite Surface Protein 1; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Recurrence; Sesquiterpenes; Sulfadoxine; Treatment Failure; Uganda | 2003 |
Evaluation of the quality of amodiaquine and sulphadoxine/pyrimethamine tablets sold by private wholesale pharmacies in Dar Es Salaam Tanzania.
Topics: Amodiaquine; Antimalarials; Drug Combinations; Drug Stability; Drug Storage; Evaluation Studies as Topic; Pharmaceutical Preparations; Pharmacies; Pyrimethamine; Quality Control; Sulfadoxine; Tanzania | 2003 |
Vendor-to-vendor education to improve malaria treatment by private drug outlets in Bungoma District, Kenya.
Topics: Adult; Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Commerce; Drug Combinations; Female; Guideline Adherence; Health Education; Humans; Kenya; Malaria; Male; Pyrimethamine; Rural Health Services; Sulfadoxine; Urban Health Services | 2003 |
Efficacy of amodiaquine alone and combined with sulfadoxine-pyrimethamine and of sulfadoxine pyrimethamine combined with artesunate.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Rural Health Services; Rwanda; Sesquiterpenes; Sulfadoxine; Treatment Outcome; Urban Health Services | 2003 |
The efficacy of antimalarial monotherapies, sulphadoxine-pyrimethamine and amodiaquine in East Africa: implications for sub-regional policy.
Topics: Africa, Eastern; Amodiaquine; Antimalarials; Chloroquine; Disease Susceptibility; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Health Policy; Humans; Malaria; Parasitic Sensitivity Tests; Predictive Value of Tests; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2003 |
Prevention of increasing rates of treatment failure by combining sulfadoxine-pyrimethamine with artesunate or amodiaquine for the sequential treatment of malaria.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Dihydropteroate Synthase; Drug Administration Schedule; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Infant; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Failure; Treatment Outcome | 2003 |
Principal role of dihydropteroate synthase mutations in mediating resistance to sulfadoxine-pyrimethamine in single-drug and combination therapy of uncomplicated malaria in Uganda.
Topics: Alleles; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Dihydropteroate Synthase; Drug Combinations; Drug Resistance, Multiple; Drug Therapy, Combination; Genetic Variation; Humans; Infant; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Time Factors; Uganda | 2004 |
Efficacy of amodiaquine in uncomplicated falciparum malaria in Nigeria in an area with high-level resistance to chloroquine and sulphadoxine/pyrimethamine.
Topics: Amodiaquine; Animals; Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Hemoglobins; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2005 |
Efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, chloroquine-sulfadoxine-pyrimethamine combination, and amodiaquine-sulfadoxine-pyrimethamine combination in Central African children with noncomplicated malaria.
Topics: Amodiaquine; Antimalarials; Central African Republic; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant; Malaria; Male; Pyrimethamine; Sulfadoxine | 2005 |
Rapid increase in resistance of Plasmodium falciparum to chloroquine-Fansidar in Uganda and the potential of amodiaquine-Fansidar as a better alternative.
Topics: Amodiaquine; Animals; Antimalarials; Child, Preschool; Chloroquine; Clinical Trials as Topic; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Membrane Proteins; Membrane Transport Proteins; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Uganda | 2005 |
Amodiaquine and combination chemotherapy for malaria.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Drug Combinations; Drug Therapy, Combination; Humans; Lactones; Malaria; Pyrimethamine; Randomized Controlled Trials as Topic; Sesquiterpenes; Sulfadoxine | 2005 |
Efficacy of chloroquine, sulfadoxine-pyrimethamine and amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria among children under five in Bongor and Koumra, Chad.
Topics: Amodiaquine; Animals; Chad; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Genes, Protozoan; Genotype; Humans; Infant; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Prospective Studies; Pyrimethamine; Sulfadoxine; Treatment Outcome; Urban Population | 2006 |
The quality of sulphadoxine-pyrimethamine and amodiaquine products in the Kenyan retail sector.
Topics: Amodiaquine; Antimalarials; Drug Combinations; Drug Stability; Drug Storage; Kenya; Nonprescription Drugs; Pharmacies; Pharmacopoeias as Topic; Product Surveillance, Postmarketing; Pyrimethamine; Quality Control; Solubility; Sulfadoxine; United States | 2005 |
Microscopy and outpatient malaria case management among older children and adults in Kenya.
Topics: Adolescent; Adult; Ambulatory Care; Amodiaquine; Antimalarials; Case Management; Child; Cross-Sectional Studies; Drug Combinations; Humans; Kenya; Malaria, Falciparum; Microscopy; Parasitemia; Population Surveillance; Prevalence; Pyrimethamine; Quinine; Sensitivity and Specificity; Sulfadoxine | 2006 |
Prevalence of malaria parasitemia among clients seeking treatment for fever or malaria at drug stores in rural Tanzania 2004.
Topics: Adult; Amodiaquine; Analgesics, Non-Narcotic; Anemia; Antimalarials; Child, Preschool; Drug Combinations; Endemic Diseases; Female; Fever; Humans; Malaria, Falciparum; Male; Parasitemia; Patient Acceptance of Health Care; Pharmacies; Prevalence; Pyrimethamine; Rural Health; Sulfadoxine; Tanzania; Trimethoprim, Sulfamethoxazole Drug Combination | 2006 |
The costs of changing national policy: lessons from malaria treatment policy guidelines in Tanzania.
Topics: Amodiaquine; Antimalarials; Chloroquine; Clinical Protocols; Drug Combinations; Health Care Costs; Health Education; Health Personnel; Health Policy; Humans; Malaria, Falciparum; Practice Guidelines as Topic; Pyrimethamine; Sulfadoxine; Tanzania | 2006 |
Roles of specific Plasmodium falciparum mutations in resistance to amodiaquine and sulfadoxine-pyrimethamine in Burkina Faso.
Topics: Amodiaquine; Animals; Antimalarials; Burkina Faso; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Genes, MDR; Humans; Membrane Proteins; Membrane Transport Proteins; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Recurrence; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2006 |
[Knowledge and practice among health workers from the Thiès region with regard to new malaria treatment policies].
Topics: Amodiaquine; Antimalarials; Chloroquine; Clinical Competence; Community Health Services; Drug Combinations; Drug Resistance; Education, Nursing; Guideline Adherence; Health Personnel; Health Policy; Health Promotion; Humans; Malaria, Falciparum; Patient Education as Topic; Practice Guidelines as Topic; Pyrimethamine; Rural Health Services; Senegal; Sulfadoxine; Workforce | 2006 |
Correlations between treatment outcome and both anti-MSP119 antibody response and erythrocyte-related genetic factors in Plasmodium falciparum malaria.
Topics: Amodiaquine; Animals; Antibodies, Protozoan; Antigens, Protozoan; Antimalarials; Child; Child, Preschool; Drug Combinations; Erythrocytes; Female; Follow-Up Studies; Gabon; Glucosephosphate Dehydrogenase; Humans; Immunoglobulin G; Infant; Kinetics; Malaria, Falciparum; Male; Merozoite Surface Protein 1; Plasmodium falciparum; Protein Subunits; Protozoan Proteins; Pyrimethamine; Sickle Cell Trait; Sulfadoxine; Treatment Outcome | 2007 |
Methodological issues in the assessment of antimalarial drug treatment: analysis of 13 studies in eight African countries from 2001 to 2004.
Topics: Africa; Amodiaquine; Antimalarials; Child, Preschool; Chloroquine; Clinical Trials as Topic; Drug Combinations; Female; Genotype; Humans; Infant; Malaria; Male; Pyrimethamine; Reverse Transcriptase Polymerase Chain Reaction; Risk; Sulfadoxine; Treatment Outcome | 2006 |
Molecular epidemiology of malaria in Cameroon. XXI. Baseline therapeutic efficacy of chloroquine, amodiaquine, and sulfadoxine-pyrimethamine monotherapies in children before national drug policy change.
Topics: Amodiaquine; Antimalarials; Cameroon; Child; Chloroquine; Drug Combinations; Health Policy; Humans; Malaria, Falciparum; Molecular Epidemiology; Pyrimethamine; Sulfadoxine | 2006 |
Cost-effectiveness study of three antimalarial drug combinations in Tanzania.
Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Cost of Illness; Cost-Benefit Analysis; Drug Combinations; Drug Costs; Ethanolamines; Fluorenes; Health Care Costs; Humans; Infant; Malaria; Practice Guidelines as Topic; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine; Tanzania; Time Factors; Treatment Outcome; World Health Organization | 2006 |
Amodiaquine, malaria, pregnancy: the old new drug.
Topics: Amodiaquine; Antimalarials; Drug Combinations; Drug Therapy, Combination; Female; Ghana; Humans; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine | 2006 |
Practical HPLC methods for the quantitative determination of common antimalarials in Africa.
Topics: Africa; Amodiaquine; Antimalarials; Chloroquine; Chromatography, High Pressure Liquid; Humans; Pyrimethamine; Reproducibility of Results; Sulfadoxine | 2007 |
Antimalarial drug combinations in vastly different settings.
Topics: Amodiaquine; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Burkina Faso; Drug Combinations; Drug Resistance, Microbial; Ethanolamines; Fluorenes; Humans; Indonesia; Malaria, Falciparum; Malaria, Vivax; Plasmodium falciparum; Pyrimethamine; Recurrence; Sulfadoxine | 2007 |
Effects of pyrimethamine-sulphadoxine, chloroquine plus chlorpheniramine, and amodiaquine plus pyrimethamine-sulphadoxine on gametocytes during and after treatment of acute, uncomplicated malaria in children.
Topics: Acute Disease; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Chlorpheniramine; Drug Combinations; Drug Therapy, Combination; Gametogenesis; Histamine H1 Antagonists; Humans; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Time Factors; Treatment Outcome | 2006 |
[Assessment of the efficacy of antimalarial drugs in Tarapacá, in the Colombian Amazon basin].
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Child; Child, Preschool; Colombia; Female; Humans; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Pyrimethamine; Sulfadoxine | 2007 |
Pharmacologic advances in the global control and treatment of malaria: combination therapy and resistance.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Dapsone; Drug Design; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Global Health; Half-Life; Humans; Lumefantrine; Malaria; Mefloquine; Pregnancy; Pregnancy Complications, Infectious; Proguanil; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine | 2007 |
Potential impact of host immunity on malaria treatment outcome in Tanzanian children infected with Plasmodium falciparum.
Topics: Amodiaquine; Animals; Antibodies, Protozoan; Child, Preschool; Drug Combinations; Drug Resistance; Female; Humans; Immunocompetence; Immunoglobulin G; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tanzania; Treatment Outcome | 2007 |
[Assessing the application of Rwanda's national protocol for uncomplicated malaria treatment in healthcare institutions in Kigali City, Rwanda].
Topics: Adult; Amodiaquine; Antimalarials; Drug Prescriptions; Drug Therapy, Combination; Female; Guideline Adherence; Health Facilities; Health Knowledge, Attitudes, Practice; Health Plan Implementation; Health Policy; Humans; Malaria; Male; National Health Programs; Nursing Staff; Physicians; Practice Patterns, Physicians'; Program Evaluation; Pyrimethamine; Rwanda; Sampling Studies; Sulfadoxine; Urban Health | 2008 |
A simple technique for the detection of anti-malarial drug formulations and their presence in human urine.
Topics: Amodiaquine; Antimalarials; Biological Assay; Biological Availability; Chloroquine; Chromatography, Thin Layer; Fraud; Humans; Malaria; Primaquine; Product Surveillance, Postmarketing; Pyrimethamine; Quality Control; Quinine; Sulfadoxine | 2006 |
Increased Plasmodium falciparum gametocyte production in mixed infections with P. malariae.
Topics: Amodiaquine; Animals; Antimalarials; Child; Drug Combinations; Gametogenesis; Humans; Malaria; Plasmodium falciparum; Plasmodium malariae; Pyrimethamine; Sulfadoxine | 2008 |
Chloroquine resistant Plasmodium falciparum malaria in Osogbo Nigeria: efficacy of amodiaquine + sulfadoxine-pyrimethamine and chloroquine + chlorpheniramine for treatment.
Topics: Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Chlorpheniramine; Clinical Protocols; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Histamine H1 Antagonists; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2008 |
The usefulness of twenty-four molecular markers in predicting treatment outcome with combination therapy of amodiaquine plus sulphadoxine-pyrimethamine against falciparum malaria in Papua New Guinea.
Topics: Amodiaquine; Animals; Antimalarials; Biomarkers; Drug Combinations; Malaria, Falciparum; Papua New Guinea; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2008 |
Mutations in PFCRT K76T do not correlate with sulfadoxine-pyrimethamine-amodiaquine failure in Pikine, Senegal.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Membrane Transport Proteins; Middle Aged; Mutation, Missense; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Senegal; Sulfadoxine; Treatment Failure | 2008 |
Molecular markers of in vivo Plasmodium vivax resistance to amodiaquine plus sulfadoxine-pyrimethamine: mutations in pvdhfr and pvmdr1.
Topics: Amodiaquine; Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Child, Preschool; Drug Combinations; Drug Resistance; Female; Genetic Markers; Humans; Infant; Malaria, Vivax; Male; Mutation, Missense; Papua New Guinea; Plasmodium vivax; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2008 |
Adherence and effectiveness of drug combination in curative treatment among children suffering uncomplicated malaria in rural Senegal.
Topics: Amodiaquine; Animals; Antimalarials; Attitude to Health; Caregivers; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Medication Adherence; Patient Compliance; Plasmodium falciparum; Pyrimethamine; Rural Health; Senegal; Sulfadoxine; Treatment Outcome | 2008 |
Different methodological approaches to the assessment of in vivo efficacy of three artemisinin-based combination antimalarial treatments for the treatment of uncomplicated falciparum malaria in African children.
Topics: Africa; Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child, Preschool; Databases as Topic; Drug Combinations; Ethanolamines; Fluorenes; Genotype; Humans; Infant; Lumefantrine; Malaria, Falciparum; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2008 |
Intermittent preventive antimalarial treatment to children (IPTc): firebreak or fire trap?
Topics: Amodiaquine; Antimalarials; Artemisinins; Child, Preschool; Decision Making; Drug Administration Schedule; Drug Combinations; Drug Resistance; Humans; Infant; Malaria; Pyrimethamine; Sulfadoxine | 2008 |
Efficacy of monotherapies and artesunate-based combination therapies in children with uncomplicated malaria in Somalia.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria; Male; Pyrimethamine; Somalia; Sulfadoxine; Treatment Outcome | 2009 |
Intermittent preventive treatment with antimalarial drugs.
Topics: Amodiaquine; Anemia; Antimalarials; Drug Administration Schedule; Drug Combinations; Humans; Infant; Kenya; Malaria; Pyrimethamine; Sulfadoxine | 2009 |
Factors related to compliance to anti-malarial drug combination: example of amodiaquine/sulphadoxine-pyrimethamine among children in rural Senegal.
Topics: Amodiaquine; Animals; Antimalarials; Caregivers; Child; Child, Preschool; Drug Administration Schedule; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Logistic Models; Malaria; Male; Medication Adherence; Plasmodium; Pyrimethamine; Rural Population; Senegal; Sulfadoxine; Surveys and Questionnaires; Treatment Outcome | 2009 |
Treatment of malaria from monotherapy to artemisinin-based combination therapy by health professionals in rural health facilities in southern Cameroon.
Topics: Adult; Aged; Amodiaquine; Antimalarials; Artemisinins; Cameroon; Child, Preschool; Drug Combinations; Health Personnel; Health Services Research; Humans; Infant; Malaria; Middle Aged; Practice Guidelines as Topic; Pyrimethamine; Quinine; Rural Health; Sulfadoxine; Surveys and Questionnaires; Young Adult | 2009 |
PfHRP2 and PfLDH antigen detection for monitoring the efficacy of artemisinin-based combination therapy (ACT) in the treatment of uncomplicated falciparum malaria.
Topics: Amodiaquine; Antigens, Protozoan; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Benin; Blood; Child, Preschool; Drug Combinations; Drug Monitoring; Drug Therapy, Combination; Ethanolamines; Fluorenes; Follow-Up Studies; Humans; Infant; L-Lactate Dehydrogenase; Malaria, Falciparum; Microscopy; Molecular Diagnostic Techniques; Protozoan Proteins; Pyrimethamine; Sensitivity and Specificity; Sulfadoxine; Treatment Outcome | 2009 |
Mode of action and choice of antimalarial drugs for intermittent preventive treatment in infants.
Topics: Amodiaquine; Antimalarials; Clinical Trials as Topic; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria; Male; Mefloquine; Pyrimethamine; Sulfadoxine | 2009 |
Comparative study of artesunate, ACTs and their combinants on the spermatic parameters of the male guinea pig.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Guinea Pigs; Male; Pyrimethamine; Sperm Count; Sperm Motility; Spermatozoa; Sulfadoxine | 2009 |
Self-reported data: a major tool to assess compliance with anti-malarial combination therapy among children in Senegal.
Topics: Amodiaquine; Antimalarials; Caregivers; Child; Child, Preschool; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Humans; Logistic Models; Malaria; Male; Medication Adherence; Plasmodium; Prescriptions; Pyrimethamine; Senegal; Sulfadoxine; Surveys and Questionnaires; Treatment Outcome | 2009 |
Plasmodium falciparum resistance to anti-malarial drugs in Papua New Guinea: evaluation of a community-based approach for the molecular monitoring of resistance.
Topics: Adolescent; Aged; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Oligonucleotide Array Sequence Analysis; Papua New Guinea; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Treatment Failure; Young Adult | 2010 |
Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Burkina Faso; Drug Combinations; Drug Resistance, Bacterial; Ethanolamines; Fluorenes; Genotype; Humans; Infant; Lumefantrine; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Recurrence; Sulfadoxine | 2010 |
Comparative study of artesunate, ACTs and their combinants on the hormonal parameters of the male guinea pig.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Dose-Response Relationship, Drug; Drug Combinations; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Guinea Pigs; Luteinizing Hormone; Male; Prolactin; Pyrimethamine; Sulfadoxine; Testosterone | 2009 |
Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Carrier State; Child; Child, Preschool; Clinical Trials as Topic; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Germ Cells; Humans; Infant; Infant, Newborn; Kenya; Malaria, Falciparum; Male; Models, Biological; Parasitemia; Plasmodium falciparum; Prevalence; Primaquine; Pyrimethamine; Self-Sustained Sequence Replication; Sulfadoxine; Tanzania; Time Factors; Treatment Outcome | 2010 |
Analysis of an ordinal outcome in a multicentric randomized controlled trial: application to a 3- arm anti- malarial drug trial in Cameroon.
Topics: Amodiaquine; Antimalarials; Cameroon; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Epidemiologic Methods; Humans; Infant; Malaria, Falciparum; Models, Statistical; Multicenter Studies as Topic; Proportional Hazards Models; Pyrimethamine; Randomized Controlled Trials as Topic; Regression Analysis; Sulfadoxine; Treatment Outcome | 2010 |
Intermittent preventive treatment to reduce the burden of malaria in children: new evidence on integration and delivery.
Topics: Amodiaquine; Antimalarials; Child, Preschool; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Malaria; Male; Pregnancy; Pyrimethamine; Sulfadoxine | 2011 |
A study of toxicity and differential gene expression in murine liver following exposure to anti-malarial drugs: amodiaquine and sulphadoxine-pyrimethamine.
Topics: Amodiaquine; Animals; Antimalarials; Drug Combinations; Drug Therapy, Combination; Gene Expression Profiling; Histocytochemistry; Liver; Male; Mice; Microarray Analysis; Oxidative Stress; Pyrimethamine; Sulfadoxine | 2011 |
Prolonged selection of pfmdr1 polymorphisms after treatment of falciparum malaria with artemether-lumefantrine in Uganda.
Topics: Alleles; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Longitudinal Studies; Malaria, Falciparum; Male; Plasmodium falciparum; Polymorphism, Genetic; Pyrimethamine; Sulfadoxine; Time Factors; Uganda | 2011 |
Management of uncomplicated malaria in children under 13 years of age at a district hospital in Senegal: from official guidelines to usual practices.
Topics: Adolescent; Amodiaquine; Antimalarials; Blood; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Guideline Adherence; Hospitals, District; Humans; Infant; Malaria; Male; Nurses; Pyrimethamine; Senegal; Sulfadoxine | 2011 |
Should malaria treatment be guided by a point of care rapid test? A threshold approach to malaria management in rural Burkina Faso.
Topics: Adult; Amodiaquine; Antimalarials; Burkina Faso; Child, Preschool; Decision Making; Drug Combinations; Fever; Humans; Malaria; Point-of-Care Systems; Probability; Pyrimethamine; Rural Health Services; Rural Population; Seasons; Sulfadoxine | 2013 |
Prevalence of molecular markers of drug resistance in an area of seasonal malaria chemoprevention in children in Senegal.
Topics: Amodiaquine; Antimalarials; Chemoprevention; Child; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Genetic Markers; Humans; Infant; Malaria, Falciparum; Male; Mutation Rate; Plasmodium falciparum; Prevalence; Pyrimethamine; Senegal; Sulfadoxine | 2013 |
Plasmodium falciparum Polymorphisms associated with ex vivo drug susceptibility and clinical effectiveness of artemisinin-based combination therapies in Benin.
Topics: Amodiaquine; Antimalarials; Artemisinins; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Inhibitory Concentration 50; Lumefantrine; Male; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Quinine; Sulfadoxine | 2014 |
Submicroscopic infections among children with adequate clinical and parasitological response (ACPR).
Topics: Amodiaquine; Antimalarials; Artemisinins; Blood; Child; Child, Preschool; DNA, Protozoan; Drug Combinations; Female; Gabon; Humans; Malaria, Falciparum; Male; Microscopy; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2014 |
Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.
Topics: Adolescent; Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Genotype; Haplotypes; Humans; Infant; Infant, Newborn; Kenya; Malaria; Malaria, Falciparum; Malawi; Male; Plasmodium falciparum; Polymorphism, Genetic; Pyrimethamine; Rwanda; Sulfadoxine; Tanzania; Uganda | 2016 |
Plasmodium falciparum Genetic Diversity in Continental Equatorial Guinea before and after Introduction of Artemisinin-Based Combination Therapy.
Topics: Amodiaquine; Antigens, Protozoan; Antimalarials; Artemisinins; Artesunate; Chloroquine; DNA Copy Number Variations; Drug Combinations; Drug Resistance; Equatorial Guinea; Female; Genetic Loci; Genetic Variation; Genotype; Humans; Malaria, Falciparum; Male; Membrane Transport Proteins; Microsatellite Repeats; Plasmodium falciparum; Point Mutation; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2017 |
Seasonal malaria chemoprevention in the Sahel.
Topics: Africa; Amodiaquine; Antimalarials; Chemoprevention; Child, Preschool; Drug Combinations; Female; Humans; Infant; Insecticide-Treated Bednets; Malaria; Male; Pharmacovigilance; Pyrimethamine; Seasons; Sulfadoxine | 2017 |
Study on testicular response to prolong artemisinin-based combination therapy treatments in guinea pigs.
Topics: Amodiaquine; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Fluorenes; Guinea Pigs; Humans; Luteinizing Hormone; Malaria; Male; Malondialdehyde; Models, Animal; Pyrimethamine; Sperm Count; Sperm Motility; Spermatogenesis; Spermatozoa; Sulfadoxine; Testis; Testosterone; Time Factors | 2018 |
Measuring the impact of seasonal malaria chemoprevention as part of routine malaria control in Kita, Mali.
Topics: Amodiaquine; Anemia; Antimalarials; Chemoprevention; Child; Child, Preschool; Cross-Sectional Studies; Drug Combinations; Female; Humans; Infant; Malaria; Male; Mali; Prevalence; Seasons; Sulfadoxine | 2017 |
Large-scale delivery of seasonal malaria chemoprevention to children under 10 in Senegal: an economic analysis.
Topics: Amodiaquine; Antimalarials; Chemoprevention; Child; Child, Preschool; Community Health Workers; Cost-Benefit Analysis; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Malaria; Male; Pyrimethamine; Seasons; Senegal; Sulfadoxine | 2017 |
Seasonal malaria chemoprevention: successes and missed opportunities.
Topics: Africa South of the Sahara; Amodiaquine; Antimalarials; Chemoprevention; Child, Preschool; Drug Combinations; Humans; Infant; Malaria; Pyrimethamine; Seasons; Sulfadoxine | 2017 |
Population Pharmacokinetic Properties of Sulfadoxine and Pyrimethamine: a Pooled Analysis To Inform Optimal Dosing in African Children with Uncomplicated Malaria.
Topics: Africa; Age Factors; Amodiaquine; Antimalarials; Biomarkers, Pharmacological; Body Weight; Chemoprevention; Child, Preschool; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Nutritional Status; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2018 |
Molecular markers of resistance to amodiaquine plus sulfadoxine-pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger.
Topics: Amodiaquine; Antimalarials; Chemoprevention; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Infant; Malaria, Falciparum; Male; Mass Drug Administration; Multidrug Resistance-Associated Proteins; Mutant Proteins; Niger; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Seasons; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2018 |
Effect of Adding Azithromycin to Seasonal Malaria Chemoprevention.
Topics: Amodiaquine; Anti-Bacterial Agents; Antimalarials; Azithromycin; Burkina Faso; Child Mortality; Child, Preschool; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Hospitalization; Humans; Incidence; Infant; Infant Mortality; Malaria; Male; Mali; Mass Drug Administration; Parasitemia; Pyrimethamine; Sulfadoxine | 2019 |
Relationship between weight status and anti-malarial drug efficacy and safety in children in Mali.
Topics: Adolescent; Amodiaquine; Antimalarials; Artesunate; Body Weight; Child; Child, Preschool; Clinical Trials as Topic; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Mali; Sulfadoxine; Treatment Outcome; Young Adult | 2019 |
Evolution of Plasmodium falciparum drug resistance genes following artemisinin combination therapy in Sudan.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; DNA, Protozoan; Drug Resistance; Drug Therapy, Combination; Genetic Markers; Genotype; Humans; Lumefantrine; Malaria, Falciparum; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sudan; Sulfadoxine | 2019 |
Effect of Seasonal Malaria Chemoprevention on Immune Markers of Exhaustion and Regulation.
Topics: Amodiaquine; Antigens, CD; Antimalarials; Biomarkers; CD4-Positive T-Lymphocytes; Child, Preschool; Drug Combinations; Female; Forkhead Transcription Factors; Humans; Infant; Lymphocyte Activation Gene 3 Protein; Malaria, Falciparum; Male; Programmed Cell Death 1 Receptor; Pyrimethamine; Seasons; Sulfadoxine; T-Lymphocytes, Regulatory | 2020 |
Serotype Profile of Nasopharyngeal Isolates of
Topics: Amodiaquine; Anti-Bacterial Agents; Antimalarials; Azithromycin; Burkina Faso; Carrier State; Chemoprevention; Child, Preschool; Drug Combinations; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Infant; Malaria; Male; Mass Drug Administration; Nasopharynx; Pneumococcal Infections; Pneumococcal Vaccines; Pyrimethamine; Seasons; Serogroup; Streptococcus pneumoniae; Sulfadoxine | 2020 |
Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study.
Topics: Adolescent; Adult; Africa, Central; Africa, Western; Amodiaquine; Antimalarials; Case-Control Studies; Chemoprevention; Child; Cost-Benefit Analysis; Drug Combinations; Drug Resistance; Feasibility Studies; Humans; Incidence; Malaria; Program Evaluation; Pyrimethamine; Safety; Seasons; Sulfadoxine; Surveys and Questionnaires; Young Adult | 2020 |
Assessment of antimalarial drug resistant markers in asymptomatic Plasmodium falciparum infections after 4 years of indoor residual spraying in Northern Ghana.
Topics: Amodiaquine; Antimalarials; Biomarkers, Pharmacological; Carrier State; Child, Preschool; Chloroquine; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Genotype; Ghana; Humans; Infant; Malaria; Malaria, Falciparum; Male; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2020 |
Evidence that seasonal malaria chemoprevention with SPAQ influences blood and pre-erythrocytic stage antibody responses of Plasmodium falciparum infections in Niger.
Topics: Amodiaquine; Antibodies, Protozoan; Antibody Formation; Antimalarials; Chemoprevention; Child, Preschool; Drug Combinations; Humans; Infant; Malaria, Falciparum; Niger; Plasmodium falciparum; Pyrimethamine; Seasons; Sulfadoxine | 2021 |
Cost-effectiveness of district-wide seasonal malaria chemoprevention when implemented through routine malaria control programme in Kita, Mali using fixed point distribution.
Topics: Amodiaquine; Antimalarials; Chemoprevention; Child, Preschool; Communicable Disease Control; Cost-Benefit Analysis; Drug Combinations; Humans; Infant; Malaria; Mali; Pyrimethamine; Seasons; Sulfadoxine | 2021 |
Modeled Impact of Seasonal Malaria Chemoprevention on District-Level Suspected and Confirmed Malaria Cases in Chad Based on Routine Clinical Data (2013-2018).
Topics: Amodiaquine; Antimalarials; Chad; Chemoprevention; Child, Preschool; Disability-Adjusted Life Years; Drug Combinations; Female; Humans; Incidence; Infant; Malaria, Falciparum; Male; Mass Drug Administration; Pyrimethamine; Seasons; Sulfadoxine | 2021 |
Risk of Plasmodium falciparum infection in south-west Burkina Faso: potential impact of expanding eligibility for seasonal malaria chemoprevention.
Topics: Adolescent; Adult; Amodiaquine; Antigens, Protozoan; Antimalarials; Burkina Faso; Child; Child, Preschool; Cross-Sectional Studies; Drug Combinations; Drug Therapy, Combination; Female; Humans; Insecticide-Treated Bednets; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Prevalence; Pyrimethamine; Risk Factors; Rural Population; Seasons; Sulfadoxine; Treatment Outcome; Young Adult | 2022 |
Effect of three years' seasonal malaria chemoprevention on molecular markers of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine and amodiaquine in Ouelessebougou, Mali.
Topics: Amodiaquine; Antimalarials; Chemoprevention; Child; Child, Preschool; Cross-Sectional Studies; Drug Combinations; Drug Resistance; Humans; Infant; Infant, Newborn; Malaria; Malaria, Falciparum; Mali; Plasmodium falciparum; Pyrimethamine; Seasons; Sulfadoxine | 2022 |
Prevalence of Plasmodium falciparum haplotypes associated with resistance to sulfadoxine-pyrimethamine and amodiaquine before and after upscaling of seasonal malaria chemoprevention in seven African countries: a genomic surveillance study.
Topics: Amodiaquine; Antimalarials; Chemoprevention; Child; Drug Combinations; Drug Resistance; Genomics; Haplotypes; Humans; Malaria; Malaria, Falciparum; Nigeria; Plasmodium falciparum; Prevalence; Pyrimethamine; Seasons; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2023 |
Seasonal Malaria Chemoprevention Drug Levels and Drug Resistance Markers in Children With or Without Malaria in Burkina Faso: A Case-Control Study.
Topics: Amodiaquine; Antimalarials; Burkina Faso; Case-Control Studies; Chemoprevention; Child; Child, Preschool; Drug Combinations; Drug Resistance; Humans; Infant; Malaria; Seasons; Sulfadoxine | 2023 |